Reference list concerning panic disorder€¦ · cingulate cortex volume reduction in patients with...

of 34

PANIC DISORDER RMA ID Number Reference List for RMA283-3 as at October 2016

52608 Abelson JL, Khan S, Liberzon I, Young EA (2007). HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depression and Anxiety, 24: 66-76.

12302 Abelson JL, Nesse RM, Weg JG, Curtis GC (1996). Respiratory psychophysiology and anxiety: Cognitive intervention in the Doxapram model of panic. Psychosomatic Medicine, 58: 302-13.

78100 Abers MS, Shandera WX, Kass JS (2014). Neurological and Psychiatric adverse effects of antiretroviral drugs. CNS Drugs, 28(2): 131-45.

78484 Ackerman WE, Phero JC, Juneja MM (1989). Panic disorder following 2-chloroprocaine. Am J Psychiatry, 146(7): 940-1.

78038 Adkins JC, Noble S (1998). Adis new drug profile - Efavirenz. Drugs, 56(6): 1055-64.

77128 Adshead Surg Lt S (2014). Clinical research. The adverse effects of mefloquine in deployed military personnel. J R Nav Med Serv, 100(3): 232-7.

48505 Aguirre BE (2005). [Comment] Commentary on "understanding mass panic and other collective responses to threat and disaster". Emergency evacuations, panic, and social psychology. Psychiatry, 68(2): 121-9.

78094 Ahmadi J, Farrashbandi H, Majdi B, et al (2005). Prevalence of mood and anxiety disorders in a sample of Iranian outpatient opioid addicts. German Journal of Psychiatry, 8(1): 5-7.

77733 Ahmadi M, Ahmadi J (2005). Substance-induced anxiety disorder in opioid dependents. Addictive Disorders & Their Treatment, 4(4): 157-9.

70500 Ahmed AI, van Mierlo P, Jansen P (2010). Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol. Gen Hosp Psychiatry, 32(6): 646, e5-7.

78234 Akindipe T, Wilson D, Stein DJ (2014). Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors. Metab Brain Dis, 29(2): 351-7.

78271

Alati R, Lawlor DA, Nakman JM, et al (2005). Is there really a 'J-shaped' curve in the association between alcohol consumption and symptoms of depression and anxiety? Findings from the Mater University study of pregnancy and its outcomes. Addiction, 100(5): 643-51.

48510 Albert U, Maina G, Bergesio C, Bogetto F (2005). Nocturnal panic and recent life events. Depression and Anxiety, 22: 52-8.

9896 Alemayehu S, Bergey GK, Barry E, Krumholz A, Wolf A, Fleming CP, Frear EJ Jr (1995). Panic attacks as ictal manifestations of parietal lobe seizures. Epilepsia, 36(8): 824-30.

12216 Alemayehu S, Bergey GK, Barry E, Krumholz A, et al (1995). Panic attacks as ictal manifestations of parietal lobe seizures. Epilepsia, 36(8): 824-30.

52119 Alkin T. (1999). [Comments] Near-drowning experiences and panic disorder. Am J Psychiatry, 156(4): 667.

of 34

52493

Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, et al (2004). Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disroders (ESEMeD) project. Acta Psychiatr Scand, 109(Suppl 420): 21-7.

78319 Alonso-Navarro H, Jimenez-Jimenez FJ, Pilo-de-la-Fuente B, et al (2009). Panic attack-like episodes possibly associated with ropinirole. Clinical Neuropharmacology, 32(4): 237-8.

78320 Alonso-Navarro H, Jimenez-Jimenez FJ (2007). Panic attack like episodes possibly associated with pramipexole therapy in Parkinson's disease. European Journal of Neurology, 14(5): e1.

12214 Aluoja A, Shlik J, Vasar V, Kingisepp P-H, et al (1997). Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers. Psychiatry Research, 66: 59-67.

70783 American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders. DSM-5, 5th Edition,. American Psychiatric Publishing, Inc.

12623 American Psychiatric Association (1994). Diagnostic & Statistical Manual of Mental Disorders (DSM-IV), 4th Edition,: 393-403. American Psychiatric Association, Washington DC.

11971 Ampollini P, Marchesi C, Signifredi R, Maggini C (1997). Temperament and personality features in panic disorder with or without comorbid mood disorders. Acta Psychiatrica Scandinavica, 95(95): 420-23.

78150 Amr MM, Halim ZS, Moussa SS (1997). Psychiatric disorders among Egyptian pesticide applicators and formulators. Environmental Research, 73: 193-9.

52105 Anderson I (2006). The new guidelines from the British Association for Psychopharmacology for anxiety disorders. Int J Psychiatry Clin Pract, 10(Suppl 3): 10-7.

78893 Andrisano C, Chiesa A, Serretti A (2013). Newer antidepressants and panic disorder: a meta-analysis. Int Clin Psychopharmacol, 28: 33-45.

12350 Angst J (1996). Comorbidity of mood disorders: A longitudinal prospective study. British Journal of Psychiatry, 168(Suppl 30): 31-37.

51111 Anon (2001). Panic disorder. Harv Ment Health Lett, 17(9): 1-5.

12825 Anonymous (1991). Treatment of Panic Disorder - Sept 25-27 1991. 9 (2): 1-24. Retrieved 8 April 1998, from NIH Consens Statement Online

52103 Apfeldorf WJ, Spielman LA, Cloitre M, et al (2000). Morbidity of comorbid psychiatric diagnoses in the clinical presentation of panic disorder. Depression and Anxiety, 12: 78-84.

51229 Arnold PD, Zai G, Richter MA (2004). Genetics of anxiety disorders. Current Psychiatry Reports, 6: 243-54.

52598 Asami T, Hayano F, Nakamura M, Yamasue H, et al (2008). Anterior cingulate cortex volume reduction in patients with panic disorder. Psychiatry & Clinical Neurosciences, 62: 322-30.

53762 Ashman TA, Spielman LA, Hibbard MR, Silver JM, et al (2004). Psychiatric challenges in the first 6 years after traumatic brain injury: cross-sequential analyses of Axis I disorders. Arch Phys Med Rehabil, 85(2): S36-42.

77551 Atigari OV, Hogan C, Healy D (2013). Doxycycline and suicidality. BMJ Case Rep, : doi:10.1136/bcr-2013-200723.

40848

Attia JR, D'Este C, Schofield PW, Brown AM, Gibson R, et al (2006). Mental health in F-111 maintenance workers: the Study of Health Outcomes in Aircraft Maintenance Personnel (SHOAMP) General Health and Medical Study. J Occup Environ Med, 48: 682-91.

52106 Australian Bureau of Statistics (2007). National survey of mental health and wellbeing: summary of results. 4326.0: 1-98.

78315 Bailey JE, Argyropoulos SV, Kendrick AH (2005). Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers. Depress Anxiety, 21: 18-25.

of 34

52478 Bandelow B, Spath C, Tichauer GA, Brooks A, et al (2002). Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Comprehensive Psychiatry, 43(4): 269-78.

47346 Bank PA, Silk KR (2001). Axis I and axis II interactions. Curr Opin Psychiatry, 14: 137-42.

32315 Baran B, Farkas M, Rajna P. Anxiety in epilepsy--based on two case reports. Ideggyogy Sz. 2002 Sep 20;55(9-10):303-10.

73349 Barrimi M, Aalouane R, Aarab C, et al (2013). Prolonged corticosteroid-therapy and anxiety-depressive disorders, longitudinal study over 12 months (Article in French). Encephale, 39(1): 59-65.

78101 Bartlett JA, Ferrando SJ (2004). Identification and management of neurologic and psychiatric side effects associated with HIV and HAART. . Retrieved 29 April 2016, from http://www.medscape.org/viewarticle/470017

43447

Basoglu M, Paker M, Paker O, Ozmen E, Marks I, Incesu C, Sahin D, Sarimurat N (1994). Psychological effects of torture: a comparison of tortured with nontortured political activists in Turkey. Am J Psychiatry, 151: 76-81.

12213 Bass C (1997). Hyperventilation syndrome: a chimera? Journal of Psychosomatic Research, 42(5): 421-26.

11834 Battaglia M, Bernardeschi L, Politi E, Bertella S, Bellodi L (1995). Comorbidity of panic and somatization disorder: a genetic-epidemiological approach. Comprehensive Psychiatry, 36(6): 411-20.

12222 Battaglia M, Bertella S, Politi E, et al (1995). Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. American Journal of Psychiatry, 152: 1362-64.

52595

Battaglia M, Pesenti-Gritti P, Medland SE, Ogliari A, et al (2009). A genetically informed study of the association between childhood separation anxiety, sensitivity to CO2, panic disorder, and the effect of childhood parental loss. Arch Gen Psychiatry, 66(1): 64-71.

52609 Beck CT (1998). Postpartum onset of panic disorder. Journal of Nursing Scholarship, 30(2): 131-5.

78498 Benyamina A, Naassila M, Bourin M (2012). Potential role of cortical 5-HT(2A) receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal. Psychiatry Res, 198(2): 307-12.

78127 Bernstein AL, Leventhal-Rochon JL (1996). Neurotoxicity related to the use of topical tretinoin (retin-A). Ann Intern Med, 124(2): 227-8.

78149 Beshwari MM, Bener A, Ameen A, et al (1999). Pesticide-related health problems and diseases among farmers in the United Arab Emirates. Int J Enviro Health Res, 9: 213-21.

78562 Besli GE, Ikiz MA, Yildirim S, et al (2015). Synthetic cannabinoid abuse in adolescents: a case series. J Emerg Med, 49(5): 644-50.

78304 Beyenburg S, Mitchell AJ, Schmidt D, et al (2005). Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy & Behaviour, 7(2): 161-71.

78222 Bhangle SD, Kramer N, Rosenstein ED (2013). Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int, 33(8): 1923-32.

41561

Bhanji NH, Chouinard G, Kolivakis T, Margolese HC (2006). Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Can J Clin Pharmacol, 13: e69-e74.

16496 Bhatia MS, Malik SC (1995). Psychiatric complications of chloroquine. Indian Pediatrics, 32: 351-3.

48514

Biederman J, Petty C, Hirshfeld-Becker DR, Henin A, et al (2006). A controlled longitudinal 5-year follow-up study of children and high and low risk for panic disorder and major depression. Psychological Medicine, 36: 1141-52.

of 34

48515 Biederman J, Petty C, Faraone SV, Henin A, et al (2006). Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. Journal of Affective Disorders, 94: 191-7.

52142 Bisaga A, Katz JL, Antonini A, Wright CE, et al (1998). Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry, 155: 1178-83.

74512 Bjorngaard JH, Gunnell D, Elvestad MB, et al (2013). The causal role of smoking in anxiety and depression: a Mendelian randomization analysis of the HUNT study. Psychol Med, 43(4): 711-9.

78037 Blanch J, Martinez E, Rousaud A, et al (2001). Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz. JAIDS, 27: 336-43.

52584 Blanchard EB, Hickling EJ, Taylor AE, Loos W (1995). Psychiatric morbidity associated with motor vehicle accidents. J Nerv Ment Dis, 183(8): 495-504.

78156 Blanc-Lapierre A, Bouvier G, Garrigou A, et al (2012). Chronic central nervous system effects of pesticides: state-of-the-art. Revue d Epidemiologic et de Sante Publique, 60(5): 389-400. [Abstract]

12489 Blazer DG (1998). Generalized anxiety disorder and panic disorder in the elderley: A review. Harvard Rev Psychiatry, 5: 18-27.

48494 Bob P, Kukleta M, Riecansky I, Susta M, et al (2006). Chaotic EEG patterns during recall of stressful memory related to panic attack. Physiol Res, 55(Suppl 1): S113-9.

48517 Bonn-Miller MO, Bernstein A, Sachs-Ericsson N, et al (2007). Associations between psychedelic use, abuse, and dependence and lifetime panic attack history in a representative sample. Journal of Anxiety Disorders, 21: 730-41.

78285 Bonn-Miller MO, Moos RH (2009). Marijuana discontinuation, anxiety symptoms, and relapse to marijuana. Addict Behav, 34(9): 782-5.

51044 Bouton ME, Barlow DH, Mineka S (2001). A modern learning theory perspective on the etiology of panic disorder. Psychological Review, 108(1): 4-32.

52602 Bouwer C, Stein D (1999). Panic disorder following torture by suffocation is associated with predominantly respiratory symptoms. Psychological Medicine, 29: 233-6.

52092 Bouwer C, Stein DJ (1997). Association of panic disorder with a history of traumatic suffocation. Am J Psychiatry, 154: 1566-70.

76197 Bowler RM, Mergler D, Rauch SS, et al (1991). Affective and personality disturbances among female former microelectronics workers. J Clin Psychol, 47(1): 41-52.

78352 Boyd IW (1998). Venlafaxine withdrawals reactions. Medical Journal of Aust, 169(2): 91-2.

11827 Brawman-Mintzer O, Lydiard RB (1997). Biological basis of generalized anxiety disorder. Journal of Clinical Psychiatry, 58(suppl 3): 16-25.

52487 Bremner JD, Innis RB, White T, Fujita M, et al (2000). SPECT [I-123]Iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry, 47: 96-106.

78125 Brenner R, Madhusoodanan S, Korn K, et al (1999). Acute anxiety and depression induced by loss of sensation and muscle control after botulinum toxin A injection. Southern Med J, 92(7): 738.

9903 Breslau N, Davis GC (1992). Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalagia, 12: 85-90.

78390 Brewer TL, Collins M (2014). A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids. J Spec Pediatr Nurs, 19(2): 119-26.

48500 Brier N (2004). Anxiety after miscarriage: a review of the empirical literature and implications for clinical practice. Birth, 31(2): 138-42.

52485 Brier N (2008). Grief following miscarriage: a comprehensive review of the literature. Journal of Women's Health, 17(3): 451-64.

of 34

49749 Brooks RB, Baltazar PL, McDowell DE, Munjack DJ, Bruns JR (1991). Personality disorders co-occurring with panic disorder with agoraphobia. J Pers Disord, 5(4): 328-36.

16206 Brueckner RP, Lasseter KC, Lin ET, et al (1998). First-time-in humans safety and pharmacokinetics of WR238605, a new antimalarial. Am J Trop Med Hyg, 58(5): 645-49.

52482 Bryant RA, Panasetis P (2005). The role of panic in acute dissociative reactions following trauma. Br J Clin Psychol, 44: 489-94.

49336 Bulik CM, Prescott CA, Kendler KS (2001). Features of childhood sexual abuse and the development of psychiatric and substance abuse disorders. Br J Psychiatry, 179: 444-9.

53464 Bulik CM, Sullivan PF, Fear JL, Joyce PR (1997). Eating disorders and antecedent anxiety disorders: a controlled study. Acta Psychiatr Scand, 96: 101-7.

28211

Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, et al (2003). "Stress" and coronary heart disease: psychosocial risk factors. National Heart Foundation of Australia position statement update. MJA, 178(6): 272-6.

52797 Burke KC, Burke JD, Regier DA, Rae DS (1990). Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry, 47: 511-18.

78493 Calcaterra NE, Barrow JC (2014). Classics in chemical neuroscience: diazepam (valium). ACS Chemical Neuroscience, 5: 253-60.

12224 Caldirola D, Perna G, Arancio C, Bertani A, et al (1997). The 35% CO2 challenge test in patients with social phobia. Psychiatry Research, 71: 41-48.

46224 Caldwell TM, Rodgers B, Jorm AF,et al (2002). Patterns of association between alcohol consumption and symptoms of depression and anxiety in young adults. Addiction, 97(5): 583-94.

78012 Cannon J, Fitzgerald B, Seed M, et al (2015). Occupational asthma from tafenoquine in the pharmaceutical industry: implications for QSAR. Occup Med, 65(3): 256-8.

48322 Caron C, Rutter M (1991). Comorbidity in child psychopathology: concepts, issues and research strategies. J Child Psychol Psychiatry, 32: 1063-80. [Abstract]

75192

Carrara VI, Phyo AP, Nwee P, et al (2008). Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand. Malar J, 233: .

52484 Carter D, Misri S, Tomfohr L (2007). Psychologic aspects of early pregnancy loss. Clin Obstet Gynecol, 50(1): 154-65.

78332 Castaneto MS, Gorelick DA, Desrosiers NA, et al (2014). Synthetic cannabinoids: epidemiology, pharmacodynamics and clinical implications. Drug Alcohol Depend, 1: 12-41.

75193 Castelli F, Odolini S, Autino B, et al (2010). Malaria Prophylaxis: A Comprehensive Review. Pharmaceuticals, 3: 3212-39.

52477

Chantarujikapong SI, Scherrer JF, Zian H, Eisen SA, et al (2001). A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Psychiatry Research, 103: 133-45.

77896 Charles BG, Blomgren A, Nasveld PE, et al (2007). Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment. Eur J Clin Pharmacol, 63: 271-8.

77898 Charles BG, Miller AK, Nasveld PE, et al (2007). Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects. Antimicrob Agents Chemother, 51(8): 2709-15.

of 34

52101 Charney DS (2003). Neuroanatomical circuits modulating fear and anxiety behaviours. Acta Psychiatr Scand, 108(Suppl 417): 38-50.

9889 Chen Y-W, Dilsaver SC (1995). Comorbidity of panic disorder in bipolar illness: Evidence from the epidemiologic catchment area survey. American Journal of Psychiatry, 152: 280-2.

11841 Chen YW, Dilsaver SC (1995). Comorbidity of panic disorder in bipolar illness: evidence from the epidemiologic catchment area survey. American Journal of Psychiatry, 152(2): 280-2.

77734 Cheslack-Postava K, Keyes KM, Lowe SR, et al (2015). Oral contraceptive use and psychiatric disorders in a nationally representative sample of women. Arch Womens Ment Health, 18(1): 103-11.

9888 Chignon J-M, Lepine J-P, Ades J (1993). Panic disorder in cardiac outpatients. American Journal of Psychiatry, 150: 780-5.

78121 Childs E, Hohoff C, Deckert J, et al (2008). Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacol, 33(12): 2791-800.

78317 Cho J, Choi YJ, Sohn J, et al (2015). Ambient ozone concentration and emergency department visits for panic attacks. J Psych Res, 62: 130-5.

12346 Christensen L, Bourgeois A, Cockroft R (1993). Electroencephalographic concomitants of a caffeine-induced panic reaction. Journal of Nervous & Mental Disease, 181(5): 327-30.

47080 Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007). Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. The Lancet, 370(9600): 1706-1713.

78617 Ciszowski K, Biedron W, Gomolka E (2014). Acute caffeine poisoning resulting in atrial fibrillation after guarana extract overdose. Przegl Lek, 71(9): 495-8.

9887 Clark DB, Hirsch BE, Smith MG, Furman JMR, Jacob RG (1994). Panic in otolaryngology patients presenting with dizziness or hearing loss. American Journal of Psychiatry, 151: 1223-5.

78116 Clattenburg RN, Donnelly CL (1997). Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. J Am Acad Child Adolesc Psychiatry, 36(11): 1606-8.

53514

Clemens JQ, Brown SO, Calhoun EA (2008). Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol, 180: 1378-82.

78616 Clemente-Suarez VJ, Robles-Perez JJ (2015). Acute effects of caffeine supplementation on cortical arousal, anxiety, physiological response and marksmanship in close quarter combat. Ergonomics, 58(11): 1842-50.

78039 Clifford DB, Evans S, Yang Y, et al (2005). Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med, 143: 714-21.

48522

Cohen H, Benjamin J, Geva AB, Matar MA, et al (2000). Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Research, 96(1): 1-13.

52610 Cohen LS, Sichel DA, Faraone SV, Robertson LM, et al (1996). Course of panic disorder during pregnancy and the puerperium: A preliminary study. Biol Psychiatry, 39: 950-4.

52613 Cohen LS, Sichel DA, Dimmock JA, Rosenbaum JF (1994). Impact of pregnancy on panic disorder: A case series. J Clin Psychiatry, 55: 284-8.

52614 Cohen LS, Sichel DA, Dimmock JA, Rosenbaum JF (1994). Postpartum course in women with preexisting panic disorder. J Clin Psychiatry, 55: 289-92.

of 34

45843 Cohen P, Crawford TN, Johnson JG, Kasen S (2005). The children in the community study of developmental course of personality disorder. Journal of Personality Disorders, 19(5) pp 466-86.

9891 Cohen SI (1995). Alcohol and benzodiazepines generate anxiety, panic and phobias. Journal of the Royal Society of Medicine, 88: 73-7.

78032 Colebunders R (2011). Cured of fear of flying. Travel Medicine and Infectious Disease, 9(2): 82.

13052

Commonwealth Department of Veteran's' Affairs (1998). Male Vietnam veterans - survey and community comparison outcomes. Morbidity of Vietnam Veterans: A study of the health of Australia's Vietnam veteran community, Vol.1. .

48516 Coryell W, Dindo L, Fyer A, Pine DS (2006). Onset of spontaneous panic attacks: a prospective study of risk factors. Psychosomatic Medicine, 68: 754-7.

78391 Coscas S, Benyamina A, Reynaud M, et al (2013). Psychiatric complications of cannabis use [article in French]. Rev Prat, 63(10): 1426-8. [Abstract]

48506 Cosci F, Abrams K, Schruers KR, Rickelt J, Griez EJ (2006). Effect of nicotine on 35% CO2-induced anxiety: a study in healthy volunteers. Nicotine & Tobacco Research, 8(4): 511-7.

78716 Cosci F, Knuts IJ, Abrams K, et al (2010). Cigarette smoking and panic: a critical review of the literature. J Clin Psychiatry, 70(5): 606-15.

48538 Cosci F, Schruers KRJ, Abrams K, Griez EJL (2007). Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship. J Clin Psychiatry, 68(6): 874-80.

48523 Craske MG, Lang AJ, Mystkowski JL, Zucker BG, et al (2002). Does nocturnal panic represent a more severe form of panic disorder? The Journal of Nervous and Mental Disease, 190(9): 611-8.

12485 Craske MG, Miller PP, Rotunda R, Barlow DH (1990). A decriptive report of features of initial unexpected panic attacks in minimal and extensive avoiders. Behav Res Ther, 28(5): 395-400.

48541 Craske MG, Waters AM (2005). Panic disorder, phobias, and generalized anxiety disorder. Annu Rev Clin Psychol, 1: 197-225.

34282 Creamer M, Burgess P & McFarlane AC (2001). Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-Being. Psychological Medicine, 31: 1237-47.

45706 Creamer M, McFarlane AC, Burgess P (2005). Psychopathology following trauma: The role of subjective experience. Journal of Affective Disorders, 86(2-3) pp 175-182.

76196 Dager SR, Holland JP, Cowley DS, et al (1987). Panic disorder precipitated by exposure to organic solvents in the work place. Am J Psychiatry, 144(8): 1056-8.

78307 Damsa C, Warczyk S, Cailhol L, et al (2006). Panic attacks associated with topiramate. J Clin Psychiatry, 67(2): 326-7.

11844 David D, Giron A, Mellman TA (1995). Panic-phobic patients and development trauma. Journal of Clinical Psychiatry, 56(3): 113-7.

12488 Davidson JRT, Kudler HS, Saunders WB, Smith RD (1990). Symptom and comorbidity patterns in World War II and Vietnam Veterans with posttraumatic stress disorder. Comprehensive Psychiatry, 131(2): 162-70.

53761 Davis TM, Bush KR, Kivlahan DR, Dobie DJ, Bradley KA (2003). Screening for substance abuse and psychiatric disorders among women patients in a VA health care system. Psychiatr Serv, 54(2): 214-8.

78318 de Cerqueira AC, Nardi AE (2011). Panic attack-like episodes possibly induced by pramipexole in a patient with young-onset Parkinson's disease. J Neuropsychiatry and Clin Neurosci, 22(3): e21.

52600 De Cristofaro MTR, Sessarego A, Pupi A, Biondi F, Faravelli C (1993). Brain perfusion abnormalities in drug-naïve, lactate-sensitive panic patients: A SPECT study. Biol Psychiatry, 33: 505-12.

of 34

47172

de Graaf R, Bijl RV, ten Have M, et al (2004). Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. Journal of Affective Disorders, 82: 461-67.

41576

de Graaf R, Bijl RV, Spijker J, Beekman ATF, Vollebergh WAM (2003). Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study. Soc Psychiatry Psychiatr Epidemiol, 38: 1-11.

52480 de Masi F (2004). The psychodynamic of panic attacks: a useful integration of psychoanalysis and neuroscience. Int J Psychoanal, 85: 311-36.

51941 de Mendonca Melo M, Martinez Ciriano JP, van Genderen PJJ (2008). Narrow vision after view-broadening travel. J Travel Med, 15(4): 278-80.

41526 De vane CL, Chaio E, Franklin M, and Kruep EJ (2005). Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. American Journal of Managed Care, 11: S344-S353.

51110 Deb S, Lyons I, Koutzoukis C, Ali I, McCarthy G (1999). Rate of psychiatric illness 1 year after traumatic brain injury. Am J Psychiatry, 156(3): 374-8.

78235 Debien C, De Chouly De Lenclave MB, Foutrein P, et al (2001). Alpha-interferon and mental disorders [article in French]. Encephale, 27(4): 308-17. [Abstract]

9872 Deci PA, Lybiard RB, Santos AB, Arana GW (1992). Oral contraceptives and panic disorder. J Clin Psychiatry, 53(5): 163-5.

11832 Deering CG, Glover SG, Ready D, Eddleman HC, Alarcon RD (1996). Unique patterns of comorbidity in posttraumatic stress disorder from different sources of trauma. Comprehensive Psychiatry, 37(5): 336-46.

9871 Dembert ML, Dinneen MP, Opsahl MS (1994). Estrogen-induced panic disorder. Am J Psychiatry, 151(8): 1246.

52492 Demyttenaere K, Bruffaerts R, Lee S, Posada-Villa J, et al (2007). Mental disorders among persons with chronic back or neck pain: results from the world mental health surveys. Pain, 129: 332-42.

45241

Department of Epidemiology & Preventive Medicine (2007). Follow-up study to the Australian Gulf War Veterans' health study. Temporal relationships between war deployment and subsequent psychological disorders, . Monash University.

11831

Diaferia G, Bianchi I, Bianchi ML, Cavedini P, Erzegovesi S, Bellodi L (1997). Relationship between obsessive-compulsive personality disorder and obsessive-compulsive disorder. Comprehensive Psychiatry, 38(1): 38-42.

11857 Dick CL, Bland RC, Newman SC (1994). Panic disorder. Acta Psychiatrica Scandinavica, Suppl 376: 45-53.

48496 Diler RS (2003). Panic disorder in children and adolescents. Yonsei Medical Journal, 44(1): 174-9.

53475

Dilsaver SC, Benazzi F, Akiskal KK, Akiskal HS (2008). Differential patterns of lifetime multiple anxiety disorder comorbidity between Latino adults with bipolar I and major depressive disorders. Bulletin of the Menninger Clinic, 72(2): 130-48.

53472 Dindo L, Coryell W (2004). Comorbid major depression and panic disorder: significance of temporal sequencing to familial transmission. J Affect Disord, 82: 119-23.

52605 Dinwiddie S, Heath AC, Dunne MP, Bucholz KK, et al (2000). Early sexual abuse and lifetime psychopathology: a co-twin-control study. Psychological Medicine, 30: 41-52.

52582 Dohrenwend BP, Turner JB, Turse NA, Adams BG, et al (2006). The psychological risks of Vietnam for U.S. veterans: a revisit with new data and methods. Science, 313: 979-82.

of 34

53471 Doughty CJ, Wells JE, Joyce PR, Olds RJ, Walsh AES (2004). Bipolar-panic disorder comorbidity within bipolar disorder families: a study of siblings. Bipolar Disorders, 6: 245-52.

77977 Dow G, Bauman R, Caridha D, et al (2006). Mefloquine induces dose-related neurological effects in a rat model. Antimicrob Agents Chemother, 50(3): 1045-53.

77978 Dow GS, Hudson TH, Vahey M, et al (2003). The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro. Malar J, 2: 14.

78186 Drug Info Clearing House (2005). Cannabis. Prevention Research Quarterly: current evidence evaluated, . .

78185 Drug Info Clearing House (2005). Prevention. Ecstasy and related drugs. Prevention Research Quarterly: current evidence evaluated, . .

12151 DuPont RL (1997). Panic disorder and addiction: the clinical issues of comorbidity. Bulletin of the Menninger Clinic, 61(2 Suppl): A54-65.

78036 Durrheim DN, Gammon S, Waner S, et al (1999). Antimalarial prophylaxis -use and adverse event in visitors to the Kruger National Park. S Afr Med J, 89(2): 170-5.

11850 Eaton WW, Badawi M, Melton B (1995). Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. American Journal of Psychiatry, 152: 967-72.

11843 Eaton WW, Kessler RC, Wittchen HU, Magee WJ (1994). Panic and panic disorder in the United States. American Journal of Psychiatry, 151(3): 413-20.

78328 Edlund MJ, Sullivan M, Steffick D, et al (2007). Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Medicine, 8(8): 647-56.

53465 Edmonds LK, Mosley BJ, Admiraal AJ, Olds RJ, et al (1998). Familial bipolar disorder: preliminary results from the Otago familial bipolar genetic study. Aust N Z J Psychiatry, 32: 623-9.

77899

Edstein MD, Nasveld PE, Kocisko DA, et al (2007). Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis. Trans R Soc Trop Med Hyg, 101(3): 226-30.

78122 Eftekhari P, Roaufy MR, Gharibzadeh S (2007). Some new psychological side effects due to anti-androgenic properties of cyproterone compound. Medical Hypotheses, 68(6): 1422-3.

78276 El-Hadidy MA, Helaly AM (2015). Medical and psychiatric effects of long-term dependence of high dose of tramadol. Substance Use & Misuse, 50(5): 582-8.

77976

Elmes NJ, Nasveld PE, Kitchener SJ, et al (2008). The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of plasmodium vivax malaria in the Southwest Pacific. Trans R Soc Trop Med Hyg, 102(11): 1095-101.

78387 Ertenli I, Ozer S, Kiraz S, et al (2012). Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int, 32: 323-30.

30771 Escalona E, Yanes L, Feo O, Maizlish N. Neurobehavioral evaluation of Venezuelan workers exposed to organic solvent mixtures. Am J Ind Med. 1995 Jan;27(1):15-27.

52098 Eser D, Schule C, Baghai T, Floesser A, et al (2007). Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology, : 479-87.

52099 Eser D, Schule C, Romeo E, Baghai TC, et al (2006). Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Psychopharmacology, : 373-87.

of 34

11856 Ettigi P, Meyerhoff AS, Chirban JT, Jacobs RJ, Wilson RR (1997). The quality of life and employment in a panic disorder. The Journal of Nervous and Mental Disease, 185(6): 368-72.

48493 Facchinetti F, Tarabusi M, Nappi G (1998). Premenstrual syndrome and anxiety disorders: a psychobiological link. Psychother Psychosom, 67: 57-60.

5784 Faravelli C, Pallanti S (1989). Recent life events and panic disorder. Am J Psychiatry, 146(5): 622-6.

77902 Farnsworth JK, Drescher KD, Nieuwsma JA, et al (2014). The role of moral emotions in military trauma: implications for the study and treatment of moral injury. Review of General Psychology, 18(4): 249-62.

77979

FDA (2013). FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects. . Retrieved 15 April 2016, from http://www.fda.gov/drugs/drugsafety/icm362227.htm

50925 Fergusson DM, Horwood J, Boden JM (2008). Abortion and mental health disorders: evidence from a 30-year longitudinal study. The British Journal of Psychiatry, 193: 444-51.

11819 Fierman EJ, Hunt MF, Pratt LA, Warshaw MG, et al (1993). Trauma and posttraumatic stress disorder in subjects with anxiety disorders. American Journal of Psychiatry, 150: 1872-4.

78287 Finfgeld D (2002). Selective serotonin reuptake inhibitor discontinuation syndrome. J Psychosoc Nurs Ment Health Serv, 40(12): 14-18.

52486 Fischer H, Andersson JLR, Furmark T, Fredrikson M (1998). Brain correlates of an unexpected panic attack: a human positron emission tomographic study. Neuroscience Letters, 251: 137-40.

12040 Fleet RP, Dupuis G, Marchand A, Burelle D, et al (1994). Panic disorder, chest pain and coronary artery disease: literature review. Canadian Journal of Cardiology, 10(8): 827-34.

11855

Flick SN, Roy-Bryne PP, Cowley DS, Shores MM, Dunner DL (1993). DSM III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates. Journal of Affective Disorders, 27: 71-9.

78732 Fowler G, Webster J, Lyons D, et al (1993). A comparison of amlodipine with enalapril in the treatment of moderate/severe hypertension. Br J Clin Pharmacol, 35: 491-8.

79307 Fox HC, Anderson GM, Tuit K, et al (2012). Prazosin effects on stress-and cue-induced craving and stress response in alcohol dependent individuals: preliminary findings. Alcohol Clin Exp Res, 36(2): 351-60.

52583 Frank E, Anderson BP (1987). Psychiatric disorders in rape victims: past history and current symptomatology. Comprehensive Psychiatry, 28(1): 77-82.

50844

Friedman S, Smith L, Fogel D, Paradis C, et al (2002). The incidence and influence of early traumatic life events in patients with panic disorder: a comparison with other psychiatric outpatients. Journal of Anxiety Disorders, 16: 259-72.

78041 Fumaz CR, Munoz-Moreno JA, Molto J, et al (2005). Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence. JAIDS, 38(5): 560-5.

78040 Fumaz CR, Tuldra A, Ferrer M, et al (2002). Quality of life, emotional status, and adherence of HIV-1 -infected patients treated with efavirenz versus protease inhibitor - containing regimens. JAIDS, 29: 224-53.

75194 Fusetti M, Eibenstein A, Corridore V, et al (1999). Mefloquine and ototoxicity: a report of 3 cases (article in Italian). La Clinica Terapeutica, 150(5): 379-82.

of 34

12158 Fyer AJ, Katon W, Hollifield M, Rassnick H, et al (1996). The DSM-IV panic disorder field trial: panic attack frequency and functional disability. Anxiety, 2: 157-66.

12621

Fyer AJ, Mannuzza S, and Coplan JD (1995). Anxiety disorders (HI Kaplan & BJ Sadock (Eds)). Comprehensive Textbook of Psychiatry, 6th Edition, Vol 1 Chapter 17: 1191-1204. Williams & Wilkins - Baltimore, Maryland USA.

78314 Garner M, Attwood A, Baldwin DS, et al (2012). Inhalation of 7.5 % carbon dioxide increases alerting and orienting attention network function. Psychopharmacology, 223: 67-73.

12303 Garssen B, Buikhuisen M, van Dyck R (1996). Hyperventilation and panic attacks. American Journal of Psychiatry, 153(4): 513-18.

9899 Garssen B, Doctorandus MB, van Dyke R (1996). Hyperventilation and panic attacks. American Journal of Psychiatry, 153(4): 513-8.

48529 Geller PA, Kerns D, Klier CM (2004). Anxiety following miscarriage and subsequent pregnancy. A review of the literature and future directions. Journal of Psychosomatic Research, 56: 35-45.

43689 Geller PA, Klier CM, Neugebauer R (2001). Anxiety disorders following miscarriage. J Clin Psychiatry, 62(6): 432-438.

78656 Gilman JM, Ramchandani VA, Davis MB, et al (2008). Why we like to drink: an fMRI study of the rewarding and anxiolytic effects of alcohol. J Neurosci, 28(18): 4583-91.

52091

Gladstone GL, Parker GB, Mitchell PB, Malhi GS, et al (2004). Implications of childhood trauma for depressed women: an analysis of pathways from childhood sexual abuse to deliberate self-harm and revictimization. Am J Psychiatry, 161: 1417-25.

75195 Gobbi F, Rossanese A, Buonfrate D, et al (2014). Epilepsy triggered by mefloquine in an adult traveler to Uganda. World J Clin Cases, 2(1): 12-15.

77913 Gogtay NJ, Ferner RE (2015). Mefloquine for malarial prophylaxis in military personnel. BMJ, 351: h5797.

11835 Goisman RM, Goldenberg I, Vasile RG, Keller MB (1995). Comorbidity of anxiety disorders in a multicenter anxiety study. Comprehensive Psychiatry, 36(4): 303-11.

11852

Goisman RM, Warshaw MG, Steketee GS, Fierman EJ, Rogers MP, Goldenberg I, Weinshenker NJ, Vasile RG, & Keller MB (1995). DSM-IV and the disappearance of agoraphobia without a history of panic disorder: new data on a controversial diagnosis. American Journal of Psychiatry, 152(10): 1438-43.

9897 Goldberg RJ (1992). Medical aspects of panic disorder. Rhode Island Medicine, 75: 265-70.

53426 Goldstein BI, Levitt AJ (2007). Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders. J Affect Disord, 103(1-3): 187-95.

9895 Goldstein RB, Weissman MM, Adams PB, et al (1994). Psychiatric disorders in relatives of probands with panic disorder and/or major depression. Arch Gen Psychiatry, 51: 383-94.

45842 Goodwin RD, Brook JS, Cohen P (2004). Panic attacks and the risk of personality disorder. Psychological Medicine, Vol 35 pp 227-35.

48509 Goodwin RD, Fergusson DM, Horwood LJ (2005). Childhood abuse and familial violence and the risk of panic attacks and panic disorder in young adulthood. Psychological Medicine, 35(6): 881-90.

53348 Goodwin RD, Wamboldt MZ, Pine DS (2003). Lung disease and internalizing disorders. Is childhood abuse a shared etiologic factor? J Psychosom Res, 55: 215-9.

11840 Gorman JM, Coplan JD (1996). Comorbidity of depression and panic disorder. Journal of Clinical Psychiatry, 57(suppl 10): 34-41.

of 34

12219 Gorman JM. Papp LA, Copland JD, et al (1994). Anxiogenic effects of CO2 and hyperventilation in patients with Panic Disorder. American Journal of Psychiatry, 151(4): 547-53.

11814 Gould RA, Ball S, Kaspi SP, Otto MW, et al (1996). Prevalence and correlates of anger attacks: a two site study. Journal of Affective Disorders, 39: 31-8.

48532 Graeff FG, Garcia-Leal C, Del-Ben CM, Guimarães FS (2005). Does the panic attack activate the hypothalamic-pituitary-adrenal axis? Anais da Academia Brasileira de Ciencias, 77(3): 477-91.

78030 Grande T, Bernasconi A, Erhart A, et al (2007). A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS One, 2(10): e1101.

48490 Gratacos M, Sahun I, Gallego X, Amador-Arjona A, et al (2007). Candidate genes for panic disorder: insight from human and mouse genetic studies. Genes, Brain, and Behavior, 6(Suppl 1): 2-23.

43446

Green BL, Grace MC, Lindy JD, Gleser GC, Leonard AC, & Kramer TL (1990). Buffalo Creek survivors in the second decade: comparison with unexposed and nonlitigant groups. Journal of Applied Social Psychology, 20: 1033-1050.

78013 Green JA, Patel AK, Patel BR, et al (2014). Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects. J Clin Pharmacol, 54(9): 995-1005.

77129

Grupp D, Froscher RW (1994). (article in German) Neuropsychiatrishe storungen nach malariaprophylaxe mit mefloquine. Eng - Neuropsychiatric disturbances after malaria prophylaxis with mefloquine. Akt Neurol, 21: 134-6.

76199 Guest M, Boggess M, D'Este C, et al (2011). An observed relationship between vestibular function and auditory thresholds in aircraft-maintenance workers. J Occup Environ Med, 53(2): 146-52.

72440 Guidotti TL (2014). Health risks and occupation as a firefighter. Medical Advisory Services, . Department of Veterans' Affairs, Commonwealth of Australia.

52604 Hagengimana A, Hinton D, Bird B, Pollack M, Pitman RK (2003). Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide. Psychiatr Res, 117: 1-9.

12483 Hagnell O, Tunving K (1972). Prevalence and nature of alcoholism in a total population. Soc Psychiatry, 7: 190-201.

78021 Hale BR, Owusu-Agyei S, Fryauff DJ, et al (2003). A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against plasmodium falciparum. Clin Infect Dis, 36(5): 541-9.

78124 Hall CE, Keegan H, Rogstad (2003). Psychiatric side effects of ofloxacin used in the treatment of pelvic inflammatory disease. Int J STD & AIDS, 14(9): 636-7.

78310 Hanna GL, Fluent TE, Fischer DJ (1999). Separation anxiety in children and adolescents treated with risperidone. Journal of Child and Adolescent Psychopharmacology, 9(4): 277-83.

12228 Harrington PJ, Schmidt NB, & Telch MJ (1996). Prospective evaluation of panic potentiation following 35% CO2 challenge in nonclinical subjects. American Journal of Psychiatry, 153: 823-25.

52093 Harter M, Baumeister H, Reuter K, Jacobi F, et al (2007). Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychsom, 76: 354-60.

78172

Hasin D, Samet S, Nunes E, et al (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. Am J Psychiatry, 163: 689-96.

of 34

78270 Haynes JC, Farrell M, Singleton N, et al (2005). Alcohol consumption as a risk factor for anxiety and depression. British Journal of Psychiatry, 187: 544-51.

52089 He Y, Zhang M, Lin EHB, Bruffaerts R, et al (2008). Mental disorders among persons with arthritis: results from the World Mental Health surveys. Psychological Medicine, 38: 1639-50.

48542 Heninger GR (1998). [Comment] Catecholamines and pathogenesis in panic disorder. Arch Gen Psychiatry, 55: 522-3.

48498 Herran A, Carrera M, Sierra-Biddle D, Ramirez L, et al (2006). [Comment] Panic disorder and the onset of agoraphobia. Psychiatry and Clinical Neurosciences, 60: 395-6.

75196 Hessen-Soderman A-C, Betgenius J, Palme IB, et al (1995). Mefloquine Prophylaxis and Hearing, Postural Control, and Vestibular Functions. J Travel Med, 2: 66-9.

14516 Hibbard MR, Uysal S, Kepler K et al (1998). Axis 1 psychopathology in individuals with traumatic brain injury. J Head Trauma Rehabil, 13(4): 24-39.

48527 Hinton D, Chau H, Nguyen L, Nguyen M, Pham T, et al (2001). Panic disorder among Vietnamese refugees attending a psychiatric clinic: prevalence and subtypes. General Hospital Psychiatry, 23: 337-44.

51045 Hiott DW, Labbate L (2002). Anxiety disorders associated with traumatic brain injuries. NeuroRehabilitation, 17: 345-55.

11839 Hirschfeld RM (1996). Panic disorder: diagnosis, epidemiology, and clinical course. Journal of Clinical Psychiatry, 57(suppl 10): 3-8.

52606 Hirshfeld-Becker DR, Micco JA, Simoes NA, Henin A (2008). High risk studies and developmental antecedents of anxiety disorders. Am J Med Genet, 148C: 99-117.

78333 Hoch E, Bonnet U, Thomasius R, et al (2015). Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int, 112: 271-8.

49762 Hoffart A, Thornes K, Hedley LM. (1995). DSM-III-R Axis I and II disorders in agoraphobic inpatients with and without panic disorder before and after psychosocial treatment. Psychiatry Research, 56:1-9.

53466 Hofmann SG (1999). Relationship between panic and schizophrenia. Depression and Anxiety, 9: 101-6.

78218 Hogh B, Clarke PD, Camus D, et al (2000). Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised double-blind study. Lancet, 356(9245): 1888-94.

78279 Hogle JM, Kaye JT, Curtin JJ (2010). Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction. Biol Psychiatry, 68(8): 719-25.

48436 Hollander E, Simeon D (2008). Anxiety Disorders. Textbook of Psychiatry, Chapter 12. Lippincott Williams & Wilkins, Philadelphia.

78158 Hong Z-R, Hong S-Y, Han M-J, et al (2008). Clinical observation of 12 farmers who believe themselves to have suffered from chronic pesticide intoxication. The Korean Journal of Internal Medicine, 23: 1-4.

78309 Hori M, Shiraishi H (1999). Risperidone-induced anxiety might also develop 'awakening' phenomenon. Psychiatry & Clinical Neurosciences, 53(6): 682.

11818 Horwath E, Johnson J, Hornig CD (1993). Epidemiology of panic disorder in African-Americans. American Journal of Psychiatry, 150: 465-9.

78174 Hosoda S, Takimura H, Shibayama M, et al (2000). Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry & Clinical Neurosciences, 54: 565-72.

9882 Hough DW, Sellers R, Cantilena LR (1995). Panic disorder in a patient taking oxaprozin. Am J Psychiatry, 152(1): 149.

78728

Huckans M, Fuller B, Wheaton V, et al (2015). A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. J Psychosom Res, 78(2): 184-92.

of 34

78465 Huffman JC, Stern TA (2007). Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci, 9: 29-45.

11823 Hunt C, Andrews G (1995). Comorbidity in the anxiety disorders: the use of a life-chart approach. Journal of Psychiatry Research, 29(6): 467-80.

78291 Iglesias M, Barreiro de Acosta M, Vazquez I, et al (2009). Psychological impact of Crohn's disease on patients in remission anxiety and depression risks. Rev Esp Enferm Dig, 101(4): 249-57.

71886 Ikin JF, McKenzie DP, Creamer MC et al (2005). War zone stress without direct combat: the Australian naval experience of the Gulf War. Journal of Traumatic Stress, 18(3): 193-204.

32984 Ikin JF, Sim MR, Creamer MC, et al (2004). War-related psychological stressors and risk of psychological disorders in Australian veterans of the 1991 Gulf War. British Journal of Psychiatry, 185: 116-26.

78481

Indulski JA, Sinczuk-Walczak H, Szymczak M, et al (1996). Neurological and neurophysiological examinations of workers occupationally exposed to organic solvent mixtures used in the paint and varnish production. Int J Occup Med Environ Health, 9(3): 235-44.

51844 Institute of Medicine (2009). Long-Term Consequences of Traumatic Brain Injury. Gulf War and Health, Volume 7. National Academy Press, Washington, D.C.

78228 Iskandar JW, Wood RL. Ali R, et al (2011). Panic attack induced by a single dose of prednisone. The Annals of Pharmacotherapy, 45(11): 1456-7.

78288

Iversen MM, Nef G, Tell GS, et al (2015). Anxiety, depression and timing of insulin treatment among people with type 2 diabetes: nine-year follow-up of the Nord-Trondelag health study, Norway. J Psychosomatic Res, 79(4): 309-15.

52491

Jacobi F, Wittchen H-U, Holting C, Hofler M, et al (2004). Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychological Medicine, 34: 597-611.

53668 Jacobs S, Hansen F, Kasl S, Ostfeld A, et al (1990). Anxiety disorders during acute bereavement: risk and risk factors. J Clin Psychiatry, 51(7): 269-74.

73105 Jacobson IG, Ryan MA, Hooper TI, et al (2008). Alcohol use and alcohol-related problems before and after military combat deployment. JAMA, 300: 663-75.

78305 Jacoby A, Snape D, Lane S, et al (2015). Self-reported anxiety and sleep problems in people with epilepsy and their association with quality of life. Epilepsy & Behaviour, 43: 149-58.

77981 Jacquerioz FA, Croft AM (2015). Drugs for preventing malaria in travellers (Review). Cochrane Database of Systematic Review, (10): CD006491.

71870 James LM, Van Kampen E, Miller RD et al (2013). Risk and protective factors associated with symptoms of post-traumatic stress, depression and alcohol misuse in OEF/OIF veterans. Military Medicine, 178(2): 159-65.

78312 Jasper BW, Hopkins RO, Van Duker H, et al (2005). Affective outcome following carbon monoxide poisoning: a prospective longitudinal study. Cog Behav Neurol, 18(2): 127-34.

77901 Javorsky DJ, Tremont G, Keitner GI, et al (2001). [Comment] Cognitive and neuropsychiatric side effects of mefloquine. J Neuropsychiatry Clin Neurosci, 13(2): 302.

52096 Jenkins R, Lewis G, Bebbington P, Brugha T, et al (2003). The National Psychiatric Morbidity Surveys of Great Britain - initial findings from the Household Survey. International Review of Psychiatry, 15: 29-42.

78326

Jensen LL, Handberg G, Helbo-Hansen HS, et al (2008). No morphine sparing effect of ketamine added to morphine for patient-controlled intravenous analgesia after uterine artery embolization. Acta Anaesthesiol Scand, 52: 479-86.

of 34

78290 Johansen A, Holmen J, Stewart R, et al (2012). Anxiety and depression symptoms in arterial hypertension the influence of antihypertensive treatment. The HUNT study, Norway. Eur J Epidemiol, 27(1): 63-72.

47533 Johnson JG, Cohen P, Smailes EM, Skodol AE, Brown J, Oldham JM (2001). Childhood verbal abuse and risk for personality disorders during adolescence and early adulthood. Comprehensive Psychiatry, 42(1): 16-23.

75197 Jousset N, Rouge-Maillart C, Turcant A, et al (2010). Suicide by skull stab wounds. Am J Forensic Med Pathol, 31(4): 378-81.

12352 Judd LL (1993). The NIMH research program in panic disorder: the present and future. Journal of Psychiatric Research, 27(Suppl 1): 221-28.

78153 Judge SJ, Savy CY, Campbell M, et al (2016). Mechanism for the acute effects of organophosphate pesticides on the adult 5-HT system. Chemico-Biological Interactions, 245: 82-9.

37049 Kamel F, Hoppin JA (2004). Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect, 112(9) pp 950-958.

9907 Karajgi B, Rifkin A, Doddi S, Kolli R (1990). The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. American Journal of Psychiatry, 147: 200-1.

78580 Karila L, Roux P, Rolland B, et al (2014). Acute and long-term effects of cannabis use: a review. Curr Pharm Des, 20(25): 4112-8.

52489 Kaschka W, Feistel H, Ebert D (1995). Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT. J Psychiat Res, 29(5): 427-34.

47536 Kasen S, Cohen P, Skodol AE, Johnson JG, Smailes E, Brook JS (2001). Childhood depression and adult personality disorder: alternative pathways of continuity. Archives of General Psychiatry, 58(3): 231-6.

47535 Kasen S, Cohen P, Skodol AE, Johnson JG, Brook JS (1999). Influence of child and adolescent psychiatric disorders on young adult personality disorder. Am J Psychiatry, 156(10): 1529-35.

48495 Katerndahl D (2004). Panic & plaques: panic disorder & coronary artery disease in patients with chest pain. J Am Board Fam Pract, 17(2): 114-26.

52090 Katerndahl D, Burge S, Kellogg N (2005). Predictors of development of adult psychopathology in female victims of childhood sexual abuse. J Nerv Ment Dis, 193: 258-64.

48488 Katerndahl DA, Palmer RF (2000). Independent relationships among outcomes and their predictors in subjects with panic attacks. The Journal of Nervous and Mental Disease, 188(10): 714-7.

11817 Katerndahl DA, Realini JP (1993). Lifetime prevalence of panic states. American Journal of Psychiatry, 150: 246-9.

12725 Katerndahl DA, Realini JP (1997). Comorbid psychiatric disorders in subjects with panic attacks. Journal of Nervous and Mental Disease, 185(11): 669-74.

53913 Katerndahl DA, Realini JP (1999). Relationship between substance abuse and panic attacks. Addictive Behaviours, 24(5): 731-6.

48487 Katschnig H, Amering M (1998). The long-term course of panic disorder and its predictors. J Clin Psychopharmacol, 18(6 Suppl 2): 6S-11S.

12622 Keane TM, King LA, King DW, Spence LA, et al (1998). Do war zone stressors predict the development of psychiatric disorders? RMA Conference Papers, : .

12221 Kellner M, Herzog L, Yassouridis A, Holsboer F, et al (1995). Possible role of atrial natriuretic hormone in Pituitary-Adrenocortical unresponsiveness in lactate-induced panic. American Journal of Psychiatry, 152: 1365-67.

78281 Kelly MM, Grant C, Cooper S, et al (2013). Anxiety and smoking cessation outcomes in alcohol-dependent smokers. Nicotine & Tobacco Research, 15(2): 364-75.

of 34

11851

Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996). The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Archives of General Psychiatry, 53: 391-9.

53667 Kendler KS, Gardner CO, Prescott CA (2001). Panic syndromes in a population-based sample of male and female twins. Psychol Med, 31: 989-1000.

52594 Kendler KS, Neale MC, Kessler RC, Health AC, Eaves LJ (1992). Childhood parental loss and adult psychopathology in women. Arch Gen Psychiatry, 49: 109-16.

78225 Kenna Ha, Poon AW, de los Angeles P, et al (2011). Psychiatric complication of treatment with corticosteroids: review with case report. Psychiatry and Clinical Neurosciences, 65: 549-60.

41518 Kessler RC (2000). The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatr Scand, 102(Suppl 406): 7-13.

53759 Kessler RC, Berglund P, Demler O, Jin R, et al (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 62: 593-602.

52107 Kessler RC, Chiu WT, Demler O, Walters EE (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 62: 617-27.

41598 Kessler RC, Keller MB, Wittchen H-U (2001). The epidemiology of generalized anxiety disorder. Psychiatric Clinics of North America, 24: 19-39.

7599

Kessler RC, McGonagle KA, Zhao S, Nelson CB, et al (1994). Lifetime and 12-Month Prevalence of DSM-III-R Psychiatry Disorders in the United States: Results From the National Comorbidity Survey. Archives of General Psychiatry, 51(1): 8-19.

12349

Kessler RC, Nelson CB, McGonagle KA, Liu J, et al (1996). Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. British Journal of Psychiatry, 168(Suppl 30): 17-30.

6745 Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry, 52(12): 1048-60.

52108 Kessler RC, Wang PS (2008). The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health, 29: 115-29.

48497 Kikuchi M, Komuro R, Oka H, Kidani T, et al (2005). Panic disorders with and without agoraphobia: comorbidity within a half-year of the onset of panic disorder. Psychiatry and Clinical Neurosciences, 59: 639-43.

32364

King DW, King LA, Gudanowski DM, et al (1995). Alternative representations of war zone stressors: relationships to posttraumatic stress disorder in male and female Vietnam veterans. Journal of Abnormal Psychology, 104(1): 184-96.

78019 Kitchener S, Nasveld P, Edstein MD (2007). Short report: tafenoquine for the treatment of recurrent plasmodium vivax malaria. Am J Trop Med Hyg, 76(3): 494-6.

77980 Kitchener SJ, Nasveld PE, Gregory RM, et al (2005). Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor. MJA, 182(4): 168-71.

9904 Klein DF (1996). Panic disorder and agoraphobia: Hypothesis hothouse. Journal of Clinical Psychiatry, 57(S6): 21-7.

52597 Klein DF, Skrobala AM, Garfinkel RS (1994/1995). Preliminary look at the effects of pregnancy on the course of panic disorder. Anxiety, 1: 227-32.

of 34

52612 Klein DF, Skrobala AM, Garfinkel RS (1994/1995). Preliminary look at the effects of pregnancy on the course of panic disorder. Anxiety, 1: 227-32.

78354 Klein SM, Benveniste H (1999). Anxiety, vocalization, and agitation following peripheral nerve block with ropivacaine. Reg Anesth Pain Med, 24(2): 175-8.

50507 Koponen S, Taiminen T, Portin R, Himanen L, et al (2002). Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry, 159: 1315-21.

78727 Kovacs P, Panczel G, Balatoni T, et al (2015). Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients. J Psychosom Res, 78(6): 579-84.

11838 Krystal JH, Deutsch DN, Charney DS (1996). The biological basis of panic disorder. Journal of Clinical Psychiatry, 57(suppl 10): 23-31.

9892 Krystal JH, Leaf PJ, Bruce ML, Charney DS (1992). Effects of age and alcoholism on the prevalence of panic disorder. Acta Psychiatr Scand, 85: 77-82.

53513 Kuch K, Cox BJ, Woszczyna CB, Swinson RP, Shulman I (1991). Chronic pain in panic disorder. J Behav Ther Exp Psychiat, 22(4): 255-9.

48526

Kuijpers PM, Denollet J, Wellens HJ, Crijns HM, Honig A (2007). Noncardiac chest pain in the emergency department: the role of cardiac history, anxiety or depression and type D personality. Eur J Cardiovasc Prev Rehabil, 14: 273-9.

52488 Kuikka JT, Pitkanen A, Lepola U, Partanen K, et al (1995). Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nuclear Medicine Communications, 16: 273-80.

52476 Kumpulainen K (2008). Psychiatric conditions associated with bullying. Int J Adolesc Med Health, 20(2): 121-32.

41514 Kushner MG, Abrams K, Borchardt C (2000). The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clinical Psychology Review, 20: 149-171.

78173 Kushner MG, Abrams K, Thuras P, et al (2005). Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol Clin Exp Res, 29(8): 1432-43.

9894 Kushner MG, Mackenzie TB, Fiszdon J, Valentiner DP, Foa E, Anderson N, Wangensteen D (1996). The effects of alcohol consumption on laboratory-induced panic and state anxiety. Arch Gen Psychiatry, 53: 264-70.

79308 Lamers CTJ, Bechara A, Rizzo M, et al (2006). Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. J Psychopharmacol, 20(2): 302-11.

78151 Lane JE, Lassiter CC, Gresen KW, et al (2002). Suspected chronic organochlorine pesticide poisoning. Arch Environ Health, 57(2): 174-5.

53424 Lautenbacher S, Spernal J, Schreiber W, Krieg J-C, (1999). Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosomatic Medicine, 61: 822-7.

78233 Le Roux G, Bruneau C, Lelievre B, et al (2015). Recreational phenethylamine poisonings reported to a French poison control center. Drug and Alcohol Dependence, 154: 46-53.

78017

Leary KJ, Riel MA, Roy MJ, et al (2009). A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers. Am J Trop Med Hyg, 81(2): 356-62.

76984 Lebain P, Juliard C, Davy JP, et al (2000). Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases. Encephale, 26(4): 67-70. [Abstract]

52088 Lee S, Tsang A, von Korff M, de Graaf R, et al (2009). Association of headache with childhood adversity and mental disorder: cross-national study. Br J Psychiatry, 194: 111-6.

of 34

9880 Lee YJ, Curtis GC, Weg JG, Abelson JL, Modell JG, Campbell KM (1993). Panic attacks induced by doxapram. Biol Psychiatry, 33: 295-7.

78022 Lell B, Faucher J-F, Missinou MA, et al (2000). Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet, 355(9220): 2041-5.

12041 Lepine JP, Lellouch J (1995). Classification and epidemiology of social phobia. European Archives of Psychiatry & Clinical Neuroscience, 244(6): 290-6.

52603 Leskin GA, Sheikh JI (2002). Lifetime trauma history and panic disorder: findings from the National Comorbidity Survey. Journal of Anxiety Disorders, 16: 599-603.

78147 Lessenger JE, Reese BE (1999). Rational use of cholinesterase activity testing in pesticide poisoning. J Am Board Fam Med, 12: 307-14.

78278 Leventhal AM, Ameringer KJ, Osborn E, et al (2013). Anxiety and depressive symptoms and affective patterns of tobacco withdrawal. Drug Alcohol Depend, 133(2): 324-9.

77905 Levin A (2013). FDA warning highlights mefloquine's mental health risks. Psychiatr News, 48(18): 1.

78162 Levin HS, Rodnitzky RL, Mick DL (1976). Anxiety associated with exposure to organophosphate compounds. Arch Gen Psychiatry, 33: 225-8.

12223 Ley R (1997). The ondine curse, false suffocation alarms, trait-state suffocation fear, and dyspnea-suffocation fear in panic attacks. Archives of General Psychiatry, 54: 677-8.

78282 Leyro TM, Zvolensky MJ (2013). The interaction of nicotine withdrawal and panic disorder in the prediction of panic-relevant responding to a biological challenge. Psychol Addict Behav, 27(1): 90-101.

78311 Li Z, Pfeiffer PN, Hoggatt KJ, et al (2011). Emergent anxiety after antidepressant initiation: a retrospective cohort study of depressed VA health system patients. Clin Ther, 33(12): 1985-92.

12042 Lim LEC (1997). Panic disorder in Singapore: clinical features and comparisons with generalised anxiety disorder. Annals of the Academy of Medicine, Singapore, 26(2): 188-92.

48489 Linden W (2003). Review: depression, social isolation, and certain life events are associated with the development of coronary heart disease. ACP J Club, 139(3): 81.

29998 Lindstrom K, Wickstrom G (1983). Psychological function changes among maintenance house painters exposed to low levels of organic solvent mixtures. Acta Psychiatr Scand, 67(Suppl 303): 81-91.

78014

Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, et al (2014). Tafenoquine plus chloroquine for the treatment and relapse prevention of plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet, 383(9922): 1049-58.

76985 Lobel HO, Coyne PE, Rosenthal PJ (1998). Drug overdoses with antimalarial agents: prescribing and dispensing errors. JAMA, 280(17): 1483.

78286 London ED, Simon SL, Berman SM, et al (2004). Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry, 61(1): 73-84.

78403 Lopez A, Billioud V, Peyrin-Biroulet C, et al (2013). Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review. Inflamm Bowel Dis, 19: 1528-33.

33558

LoSasso GL, Rapport LJ, Axelrod BN, Whitman RD (2002). Neurocognitive sequelae of exposure to organic solvents and (meth)acrylates among nail-studio technicians. Neuropsychiatry Neuropsychol Behav Neurol, 15(1) pp 44-55.

78273 Low NC, Lee SS, Johnson JG, et al (2008). The association between anxiety and alcohol versus cannabis abuse disorders among adolescents in primary care settings. Family Practice, 25(5): 321-7.

of 34

12343 Lteif GN, Mavissakalian MR (1995). Life events and panic disorder/agoraphobia. Comprehensive Psychiatry, 36(2): 118-22.

11833 Lteif GN, Mavissakalian MR (1996). Life events and panic disorder/ agoraphobia: a comparison at two time periods. Comprehensive Psychiatry, 37(4): 241-4.

78284

Luebbe AM, Bell DJ (2009). Mountain Dew or mountain don't?: a pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th- grade students. Journal of School Health, 79(8): 380-7.

15871 Lysack JT, Lysack CL, Kvern B (1998). A severe adverse reaction to mefloquine and chloroquine prophylaxis. Australian Family Physician, 27(12): 1119-20.

48492 MacKinnon DF, Zamioski R (2006). Panic comorbidity with bipolar disorder: what is the manic-panic connection? Bipolar Disorders, 8: 648-64.

53425 MacKinnon DF, Zandi PP, Cooper J, Potash JB, et al (2002). Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry, 159: 30-5.

78155 Malekirad AA, Faghih M, Mirabdollahi M, et al (2013). Neurocognitive, mental health, and glucose disorders in farmers exposed to organophosphorus pesticides. Arh Hig Rada Toksikol, 64: 1-8.

52143 Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, et al (1998). Decreased brain GABAa-benzodiazepine receptor binding in panic disorder. Arch Gen Psychiatry, 55: 715-20.

53512 Manfredini D, Bandettini di Poggio A, Cantini E, Dell'Osso L (2004). Mood and anxiety psychopathology and temporomandibular disorder: a spectrum approach. J Oral Rehab, 31: 933-40.

12342

Manfro GG, Otto MW, McArdle ET, Worthington JJ III, et al (1996). Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. Journal of Affective Disorders, 41: 135-39.

78227 Mansfield LE (2008). [Comment] Neuropsychiatric disorders during intranasal corticosteroid therapy. Ann Allergy Asthma Immunol, 101(3): 333-4.

11821 Marriott PF, Greenwood KM, Armstrong SM (1994). Seasonality in panic disorder. Journal of Affective Disorders, 31: 75-80.

11828 Marshall JR (1997). Alcohol and substance abuse in panic disorder. Journal of Psychiatry, 58(suppl 2): 46-9.

11815

Marten PA, Brown TA, Barlow DH, Borkovec TD, Shear MK, Lydiard RB (1993). Evaluation of the ratings comprising the associated symptom criterion of DSM-III-R generalised anxiety disorder. The Journal of Nervous and Mental Disease, 181(11): 676-82.

51228 Masi G, Favilla L, Romano R (1999). Panic disorder in children and adolescents. Panminerva Med, 41: 153-6.

77906 Maszaros K, Kasper S (1996). Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (lariam) administration. [article in German]. Nervenarzt, 67(5): 404-6. [Abstract]

78229 Mathis AS, Liu MT, Adamson RT, et al (2007). Retrospective analysis of early steroid-induced adverse reactions in kidney and kidney-pancreas transplant recipients. Transplantation Proceedings, 39(1): 199-201.

48502 Mawson AR (2005). Understanding mass panic and other collective responses to threat and disaster. Psychiatry, 68(2): 95-113.

76652 Mawson AR (2013). Mefloquine use, psychosis, and violence: a retinoid toxicity hypothesis. Med Sci Monit, 19: 579-83.

76940 Maxwell NM, Nevin RL, Stahl S, et al (2015). Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy. Clin Case Rep, 3(6): 379-387.

of 34

48535 Mayer EA, Craske M, Naliboff BD (2001). Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry, 62(Suppl 8): 28-36.

79292

Mayo Clinic (2014). Healthy lifestyle: nutrition and healthy eating. . Retrieved 19 August 2016, from http://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/in-depth/caffeine/art-20049372?pg=1&p=1

9874 McCann UD, Ricaurte GA (1991). Lasting neuropsychiatric sequelae of (± ) methylenedioxymethamphetamine ("ecstacy") in recreational users. J Clin Psychopharmacol, 11(5): 302-305.

9877 McCann UD, Ricaurte GA (1992). MDMA ("ecstasy") and panic disorder: induction by a single dose. Biol Psychiatry, 32: 950-3.

77914 McCarthy JS (2005). Malaria chemoprophylaxis: in war and peace. MJA, 4: 148-9.

69474 McCarthy S (2015). Malaria prevention, mefloquine neurotoxicity, neuropsychiatric illness, and risk-benefit analysis in the Australian Defence Force. Journal of Parasitology Research, ID287651: 23 pages.

12487 McFarlane AC, Papay P (1992). Multiple diagnoses in posttraumatic stress disorder in the victims of a natural disaster. Journal of Nervous and Mental Disease, 180(8): 498-504.

49612

McGlashan TH, Grilo CM, Skodol AE, Gunderson JG, Shea MT, Morey LC et al. (2000). The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand, 102:256-264.

9875 McGuire PK, Cope H, Fahy TA (1994). Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ("ecstacy"). Br J Psychiatry, 165: 391-5.

73106 McKenzie D (2010). An holistic view of post-traumatic stress disorder. Journal of Military Health, 18: 24-6.

49594 McLaughlin KA, Mennin DS. (2005). Clarifying the temporal relationship between dependent personality disorder and anxiety disorder. Clin Psychol Sci Prac, 12:417-420.

78729 McNutt MD, Liu S, Manatunga A, et al (2012). Neurobehavioral effects of interferon-a in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacol, 37: 1444-54.

78355 McWhirter L, Morris S (2010). A case report of inpatient detoxification after kratom (mitragyna speciosa) dependence. Eur Addict Res, 16: 229-31.

43437 McWilliams LA, Cox BJ, & Enns MW (2003). Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain, 106: 127-133.

75198 Meier CR, Wilcock K, Jick SS (2004). The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf, 27(3): 203-13.

48499 Mellman TA (2006). Sleep and anxiety disorders. Psychiatr Clin North Am, 29: 1047-58.

11842 Mellman TA, Kulick-Bell R, Ashlock LE, Nolan B (1995). Sleep events among veterans with combat-related posttraumatic stress disorder. American Journal of Psychiatry, 152(1): 110-5.

12486

Mellman TA, Randolph CA, Brawman-Mintzer O, Flores LP, et al (1992). Phenomenology and course of psychiatric disorders associated with combat-related posttraumatic stress disorder. Am J Psychiatry, 149(11): 1569-74.

11845

Merikangas KR, Angst J, Eaton W, Canino G, et al (1996). Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. British Journal of Psychiatry, 168(suppl 30): 58-67.

of 34

53666 Merikangas KR, Stevens DE, Fenton B, Stolar M, et al (1998). Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med, 28: 773-88.

48520 Messenger C, Shean G (1998). The effects of anxiety sensitivity and history of panic on reactions to stressors in non-clinical sample. Journal of Behaviour Therapy and Experimental Psychiatry, 29: 279-88.

78747 Mihanovic M, Restek-Petrovic B, Bodor D, et al (2010). Suicidality and side effects of antidepressants and antipsychotics. Psychiatria Danubina, 22(1): 79-84.

53441 Milrod B, Leon AC, Shear MK (2004). [Comment] Can interpersonal loss precipitate panic disorder? Am J Psychiatry, 161(4): 758-9.

70479 Mojtabai R, Crum RM (2013). Cigarette smoking and onset of mood and anxiety disorders. Am J Public Health, 103(9): 1656-65.

78313 Monkul ES, Onur E, Tural U, et al (2010). History of suffocation, state-trait anxiety, and anxiety sensitivity in predicting 35% carbon dioxide-induced panic. Psychiatry Res, 179(2): 194-7.

51046 Moore EL, Terryberry-Spohr L, Hope DA (2006). Mild traumatic brain injury and anxiety sequelae: a review of the literature. Brain Injury, 20(2): 117-32.

72566 Moreira FA, Crippa JA (2009). The psychiatric side-effects of rimonabant. Revista Brasileira de Psiquiatria, 31(2): 145-53.

48519 Morissette SB, Brown TA, Kamhols BW, Gulliver SB (2006). Differences between smokers and nonsmokers with anxiety disorders. Journal of Anxiety Disorders, 20(5): 597-613.

22686

Morris P, Raphael B, Bordujenko A (eds.) (1999). Repatriation Medical Authority Consensus Conference Proceedings: Stress and Challenge - Health and Disease, Brisbane February 9-11, 1998, . Repatriation Medical Authority, Brisbane.

30334 Morrow LA, Gibson C, Bagovich GR, Stein L, et al (2000). Increased incidence of anxiety and depressive disorders in persons with organic solvent exposure. Psychosomatic Medicine, 62: 746-750.

30447 Morrow LA, Kamis H, Hodgson M. Psychiatric symptomatology in persons with organic solvent exposure. Journal of Consulting & Clinical Psychology 1993;61(1):171-174.

30475 Morrow LA, Ryan C, Goldstein G, et al (1989). A distinct pattern of personality disturbances following exposure to mixtures of organic solvents. Journal of Occupational Medicine, 31(9): 743-6.

72426 Mott JM, Graham DP, Teng EJ (2012). Perceived threat during deployment: risk factors and relation to Axis I disorders. Psychological Trauma:Theory, Research Practice and Policy, 4(6): 587-595.

70553 Moylan S, Jacka FN, Pasco JA, et al (2012). Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med, : Epub.

78306 Muether PS, Welsandt G, Dietlein TS (2011). Panic after LASIK: acute medication-induced myopic recurrence after refractive surgery [article in German]. Ophthalmologe, 108(2): 164-6. [Abstract]

78633 Mula M, Pini S, Cassano GB (2007). The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol, 27: 263-72.

78736 Muldoon MF, Waldstein SR, Ryan CM, et al (2002). Effects of six anti-hypertensive medications on cognitive performance. J Hypertens, 20: 1643-52.

46850 Muller JE, Koen L, Soraya S, Emsley RA, Stein DJ (2004). Anxiety disorders and schizophrenia. Current Psychiatry Reports, 6: 255-61.

78280 Murphy HM, Ihekoronze C, Wideman CH (2011). Zolpidem-induced changes in activity, metabolism, and anxiety in rats. Pharmacol Biochem Behav, 98(1): 81-6.

of 34

78329

Naef M, Curatolo M, Petersen-Felix S, et al (2003). The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. Pain, 105: 79-88.

48518 Nardi AE, Lopes FL, Valenca AM, Freire RC, et al (2007). Caffeine challenge test in panic disorders and depression with panic attacks. Comprehensive Psychiatry, 48: 257-63.

77903 Nash WP, Litz BT (2013). Moral injury: a mechanism for war-related psychological trauma in military family members. Clin Child Fam Psych Rev, 16: 365-75.

78015

Nasveld P, Kitchener S, Edstein M, et al (2002). Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel. Trans R Soc Trop Med Hyg, 96(6): 683-4.

77907

Nasveld PE, Edstein MD, Reid M, et al (2010). Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother, 54(2): 792-8.

78648 Nehlig A (2016). Effects of coffee/caffeine on brain health and disease: what should I tell my patients. Pract Neurol, 16(2): 89-95.

78464 Nelson ME, Bryant SM, Aks SE (2012). Melanotan II injection resulting in systematic toxicity and rhabdomyolysis. Clinical Toxicology, 50: 1169-73.

53427 Nemeroff CB, Harris RW (2002). Comorbidity of mood and anxiety disorders: the rule, not the exception? Am J Psychiatry, 159(1): 3-4.

77904

Nevin RL (2009). Low validity of self-report in identifying recent mental health diagnosis among U.S service members completing pre-deployment health assessment (PreDHA) and deployed to Afghanistan, 2007: a retrospective cohort study. BMC Public Health, 9: 376.

77908 Nevin RL (2010). Mefloquine prescriptions in the presence of contraindications: prevalence among US military personnel deployed to Afghanistan, 2007. Pharmacoepidemiol Drug Saf, 19: 206-10.

75200 Nevin RL (2012). [Comment] Mefloquine Blockade of Connexin 36 and Connexin 43 Gap Junctions and Risk of Suicide. Biol Psychiatry, 71: e1-e2.

75199 Nevin RL (2012). [Comment] Hallucinations and persecutory delusions in Mefloquine-Associated suicide. Am J Forensic Med Pathol, 33(2): e8.

75201 Nevin RL (2012). Limbic encephalopathy and central vestibulopathy caused by mefloquine: A case report. Travel Medicine and Infectious Disease, 10: 144-51.

77909 Nevin RL (2014). Idiosyncratic quinoline central nervous system toxicity: historical insights into the chronic neurological sequelae of mefloquine. Int J Parasitol Drugs Drug Resist, 4: 118-25.

76942 Nevin RL (2015). Mefloquine and posttraumatic stress disorder. Textbook of military medicine. Forensic and ethical issues in military behavioural health, 19: 277-96. Borden Institute, Washington D.C.

77911 Nevin RL (2015). Rational risk-benefit decision-making in the setting of military mefloquine policy. J Parasitol Res, Article ID 260106: .

60085

Nevin RL (2016). The mefloquine intoxication syndrome: a significant potential confounder in the diagnosis and management of PTSD and other chronic deployment-related neuropsychiatric disorders. Post-Traumatic Stress Disorder and Related Diseases in Combat Veterans, : Springer International Switzerland. .

77900 Nevin RL, Pietrusiak PP, Caci JB (2008). Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan. Malaria Journal, 7: 30.

of 34

53349

Newman DL, Moffitt TE, Caspi A, Magdol L, Silva PA (1996). Psychiatric disorder in a birth cohort of young adults: prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. J Consult Clin Psychol, 64(3): 552-62.

12344 Newman SC, Bland RC (1994). Life events and the 1-year prevalence of major depressive episode, generalized anxiety disorder, and panic disorder in a community sample. Compr Psychiatry, 35(1): 76-82.

11836 Newman SC, Bland RC (1994). Life events and the 1-year prevalence of major depressive episode, generalized anxiety disorder, and panic disorder in a community sample. Comprehensive Psychiatry, 35(1): 76-82.

49595 Ng HM, & Bornstein RF. (2005). Comorbidity of dependent personality disorder and anxiety disorders:a meta-analytic review. Clin Psychol Sci Prac, 12:395-406.

41503 Nicholson B & Verma S (2004). Comorbidities in chronic neuropathic pain. Pain Medicine, 5: S1-S27.

78322 Niesters M, Martini C, Dahan A (2014). Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol, 77(2): 357-67.

74424 Nilson LN, Karlson B, Nise G, et al (2010). Delayed manifestations of CNS effects in formerly exposed printers - a 20-year follow-up. Neurotoxicology and Teratology, 32(6): 620-26.

48540 Ninan PT, Dunlop BW (2005). Neurobiology and etiology of panic disorder. J Clin Psychiatry, 66(Suppl 4): 3-7.

78353 Nisijima K, Shimizu M, Abe T, et al (1996). A case of serotonin syndrome induced by concomitant treatment with low-dose trazodone and amitriptyline and lithium. Int Clin Psychopharmacol, 11: 289-90.

52086 Nixon RDV, Bryant RA (2003). Peritraumatic and persistent panic attacks in acute stress disorder. Behav Res Ther, 41: 1237-42.

52479 Nixon RDV, Bryant RA (2003). Peritraumatic and persistent panic attacks in acute stress disorder. Behav Res Ther, 41: 1237-42.

52085 Nixon RDV, Resick PA, Griffin MG (2004). Panic following trauma: the etiology of acute posttraumatic arousal. Journal of Anxiety Disorders, 18: 193-210.

77735 Nkogho Mengue PG, Abdous B, Berbiche D (2014). Benzodiazepine dependence and the risk of depression and anxiety disorders: seniors' health study. [article in French]. L'Encéphale, 40(3): 216-22.

52596 Nordahl TE, Semple WE, Gross M, Mellman TA, et al (1990). Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology, 3(4): 261-72.

52615 Northcott CJ, Stein MB (1994). Panic disorder in pregnancy. J Clin Psychiatry, 55: 539-42.

48503 Norwood AE (2005). [Comment] Commentary on "understanding mass panic and other collective responses to threat and disaster". Debunking the myth of panic. Psychiatry, 68(2): 114.

41600 Noyes R Jr (2001). Comorbidity in generalized anxiety disorder. Psychiatric Clinics of North America, 24: 41-55.

52087

Oakley Browne MA, Wells E, Scott KM, McGee MA (2006). Lifetime prevalence and projected lifetime risk of DSM-IV disorders in Te Rau Hinengaro: the New Zealand mental health survey. Aust N Z J Psychiatry, 40: 865-74.

9883 Opler LA, Gorman JM (1994). Pentoxifylline and panic attacks. Am J Psychiatry, 152(2): 290.

32171 Orbaek P, Nise G. Neurasthenic complaints and psychometric function of toluene-exposed rotogravure printers. Am J Ind Med. 1989;16(1):67-77

51640 Ormel J, Von Korff M, Burger H, Scott K, et al (2007). Mental disorders among persons with heart disease - results from the World Mental Health Surveys. General Hospital Psychiatry, 29(4): 325-34.

of 34

57458

O'Toole BI, Catts SV, Outram S, Pierse KR, Cockburn J (2009). The physical and mental health of Australian Vietnam veterans 3 decades after the war and its relation to military service, combat, and post-traumatic stress disorder. Am J Epidemiol, : [Epub ahead of print].

3039

O'Toole BI, Marshall RP, Grayson DA, Schureck RJ, et al (1996). The Australian Vietnam Veterans Health Study: III. Psychological Health of Australian Vietnam Veterans and its relationship to combat. Int J Epidemiol, 25(2): 331-40.

3038 O'Toole BI, Marshall RP, Grayson DA et al (1996). The Australian Vietnam Veterans Health Study: - II. Self-reported health of veterans compared with the Australian population. Int J Epidemiol, 25(2): 319-30.

3037 O'Toole BI, Marshall RP, Grayson DA, Schureck RJ, et al (1996). The Australian Vietnam Veterans Health Study: 1.Study design and response bias. Int J Epidemiol, 25(2): 307-18.

57459

O'Toole BI, Outram S, Catta SV, Pierse MA (2009). The mental health of partners of Australian Vietnam veterans three decades after the war and its relation to veteran military service, combat and PTSD. Australian Vietnam Veterans Family Health Study, . ANZAC Research Institute, Sydney.

48507 Pacchierotti C, Castrogiovanni A, Chiara C, Stefano L, et al (2004). Panic disorder in menopause: a case control study. Maturitas, 48: 147-54.

11837 Page AC, Andrews G (1996). Do specific anxiety disorders show specific drug problems? Australian & New Zealand Journal of Psychiatry, 30: 410-4.

9876 Pallanti S, Mazzi D (1992). MDMA (ecstasy) precipitation of panic disorder. Biol Psychiatry, 32: 91-5.

12220 Papp LA, Klein DF, Gorman JM (1993). Carbon Dioxide hypersensitivity, hyperventilation, and panic disorder. American Journal of Psychiatry, 150(8): 1149-57.

76941

Park H, Reber BH, Chon M-G (2015). Tweeting as health communication: health organizations' use of twitter for health promotion and public engagement. Journal of Health Communication, [Epub ahead of print]0: 1-11.

78563 Parrott DJ, Gallagher KE, Zeichner A (2012). Liquid courage or liquid fear: alcohol intoxication and anxiety facilitate physical aggression. Substance Use & Misuse, 47(7): 774-86.

53440 Parvin MM, Swartz CM; MacKinnon DF (2002). [Comments] Mania or anxiety disorders linked to panic disorder. Am J Psychiatry, 159(12): 2115-6.

25590 Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M and Hall W (2002). Cannabis use and mental health in young people: cohort study. BMJ, 325(7374): 1195-1198.

78316 Perna G, Cocchi S, Allevi L, et al (1999). A long-term prospective evaluation of first-degree relatives of panic patients who underwent the 35% CO2 challenge. Biol Psychiatry, 45: 365-7.

78730 Perron BE, Howard MO (2009). Adolescent inhalant use, abuse and dependence. Addiction, 104(7): 1185-92.

78327 Persson J (2008). The ketamine enigma. Acta Anaesthesiol Scand, 52: 453-5.

78177 Peterson AL, Seegmiller RA, Schindler LS (2011). Severe neuropsychiatric reaction in a deployed military member after prophylactic mefloquine. Case Reports in Psychiatry, article ID 350417: .

48512 Pfefferbaum B, Stuber J, Galea S, Fairbrother G (2006). Panic reactions to terrorist attacks and probable posttraumatic stress disorder in adolescents. Journal of Traumatic Stress, 19(2): 217-28.

78735 Piedad J, Rickards H, Besag FM, et al (2012). Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy. CNS Drugs, 26(4): 319-35.

48536 Pigott TA (2003). Anxiety disorders in women. Psychiatr Clin North Am, 26: 621-72.

of 34

11830

Pini S, Cassano GB, Simonini E, Savino M, Russo A, Montgomery SA (1997). Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. Journal of Affective Disorders, 42: 145-53.

78662 Plebani JG, Ray LA, Morean ME, et al (2012). Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res, 36(6): 972-83.

9885 Pohl R, Yeragani VK, Baon R, Lycaki H, McBride R (1992). Smoking in patients with panic disorder. Psychiatry Research, 43: 253-62.

78226

Pokladnikova J, Meyboom RH, Vlcek J, et al (2008). Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of international pharmacovigilance programme of the World Health Organization. Ann Allergy Asthma Immunol, 101(1): 67-73.

41607 Pollack MH (2005). Comorbid anxiety and depression. J Clin Psychiatry, 66(Suppl 8): 22-29.

53347

Pollack MH, Otto MW, Rosenbaum JF, Sachs GS (1992). Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Comprehensive Psychiatry, 33(2): 78-83.

12624 Pollard CA, Pollard HJ, Corn KJ (1989). Panic onset and major events in the lives of agoraphobics: A test of contiguity. Journal of Abnormal Psychology, 98(3): 318-21.

78494 Poromaa IS, Segebladh B (2012). Adverse mood symptoms with oral contraceptives. Acta Obstet Gynecol Scand, 91: 420-7.

77124 Prescrire International (2014). Mefloquine: persistent vestibular disorders. Prescrire International, 23(150): 157.

52607 Preter M, Klein DF (2008). Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsychopharmacol Biol Psychiatry, 32(3): 603-12.

45847 Pukrop R, Krischer M (2005). Changing views about personality disorders: comment about the prospective studies CIC, CLPS, and MSAD. Journal of Personality Disorders, 19(5): 563-72.

78733 Quek KF, Low WY, Razack AH, et al (2000). The psychological effects of treatments for lower urinary tract symptoms. BJU Int, 86: 630-3.

76939

Quinn JC (2015). Complex membrane channel blockade: a unifying hypothesis for the prodromal and acute neuropsychiatric sequelae resulting from exposure to the antimalarial drug mefloquine. Journal of Parasitology Research, ID 368064: 12 pages.

73330 Rabinak CA, Nirenberg MJ (2010). Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol, 67(1): 58-63.

77934 Rajapakse S, Rodrigo C, Fernando SD (2015). Tafenoquine for preventing relapse in people with plasmodium vivax malaria (review). The Cochrane Collaboration, . .

12347 Rapaport MH (1994). Carbon-dioxide-induced panic. American Journal of Psychiatry, 151(2): 292-93.

12484 Rapee RM, Litwin EM, Barlow DH (1990). Impact of life events on subjects with panic disorder and on comparison subjects. Am J Psychiatry, 147(5): 640-44.

48504

Raphael B (2005). [Comment] Commentary on "understanding mass panic and other collective responses to threat and disaster". Crowds and other collectives: complexities of human behaviours in mass emergencies. Psychiatry, 68(2): 115-20.

52601

Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA (1997). The functional neuroanatomy of anxiety: A study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry, 42: 446-52.

of 34

48508

Reichborn-Kjennerud T, Roysamb E, Tambs K, Torgersen S, et al (2004). Genetic and environmental influences on the association between smoking and panic attacks in females: a population-based twin study. Psychological Medicine, 34: 1271-7.

52599 Reiman EM, Raichle ME, Butler FK, Herscovitch P, Robins E (1984). A focal brain abnormality in panic disorder, a severe form of anxiety. Nature, 310: 683-5.

52809 Reiman EM, Raichle ME, Robins E, Mintun MA, et al (1989). Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry, 46: 493-500.

78663 Richards G, Smith A (2015). Caffeine consumption and self-assessed stress, anxiety, and depression in secondary school children. J Psychopharmacol, 29(12): 1236-47.

75202 Ringqvist A, Bech P, Glenthoj B, et al (2015). Acute and long-term psychiatric side effects of mefloquine: A follow-up on Danish adverse event reports. Travel Medicine and Infectious Disease, 13: 80-8.

75203 Ritchie EC, Block J, Nevin RL (2013). Psychiatric side effects of Mefloquine: applications to forensic psychiatry. J Am Acad Psychiatry Law, 41: 224-35.

53760 Robinson J, Sareen J, Cox BJ, Bolton J (2009). Self-medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample. J Anxiety Dis, 23: 38-45.

78496 Robinson SA, Dowell M, Pedulla D, et al (2004). Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanism? Medical Hypotheses, 63(2): 268-73.

78272 Rodgers B, Korten AE, Jorm AF, et al (2000). Risk factors for depression and anxiety in abstainers, moderate drinkers and heavy drinkers. Addiction, 95(12): 1833-45.

11822 Rogers MP, White K, Warshaw MG, Yonkers KA, et al (1994). Prevalence of medical illness in patients with anxiety disorders. International Journal of Psychiatry in Medicine, 24(1): 83-96.

78283

Rogers PJ, Hohoff C, Heatherley SV, et al (2010). Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ASORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacol, 35(9): 1973-83.

78274 Romeo E, Brancati A, De Lorenzo A, et al (1996). Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clinical Neurophamacology, 19(4): 366-9.

75205

Ronn AM, Ronne-Rasmussen J, Gotzsche P, et al (1998). Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study. Tropical Medicine and International Health, 3(2): 83-8.

11848

Ros E, Armengol X, Grande L, Toledo-Pimentel V, Lacima G, Sanz G (1997). Chest pain at rest in patients with coronary artery disease. Myocardial ischemia, esophageal dysfunction, or panic disorder? Digestive Diseases and Sciences, 42(7): 1344-53.

9878 Rosen MI, Kosten T (1992). Cocaine-associated panic attacks in methadone-maintained patients. Am J Drug Alcohol Abuse, 18(1): 57-62.

78164 Rosenstock L, Daniell W, Barnhart S, et al (1990). Chronic neuropsychological sequelae of occupational exposure to organophosphate insecticides. Am J Ind Med, 18: 321-5.

78148 Rosenthal NE, Cameron CL (1991). Exaggerated sensitivity to an organophosphate pesticide. Am J Psychiatry, 148(2): 270.

48539 Ross LE, McLean LM (2006). Anxiety disorders during pregnancy and postpartum period: a systematic review. J Clin Psychiatry, 67(8): 1285-98.

51047 Roth WT (2005). Physiological markers for anxiety: panic disorder and phobias. Int J Psychophysiol, 58: 190-8.

of 34

48528 Roth WT, Gomolla A, Meuret AE, Alpers GW, et al (2002). High altitudes, anxiety, and panic attacks: is there a relationship? Depression and Anxiety, 16: 51-8.

52474 Roth WT, Wilhelm FH, Pettit D (2005). Are current theories of panic falsifiable? Psychological Medicine, 131(2): 171-92.

52097 Roy-Brune PP, Cowley DS (1998). [Comment] Search for pathophysiology of panic disorder. Lancet, 352: 1646-7.

78664 Roy-Byrne P (2015). Treatment-refractory anxiety; definition, risk factors, and treatment challenges. Dialogues Clin Neurosci, 17: 191-206.

52102 Roy-Byrne PP, Cowley DS (1998). [Comment] Search for pathophysiology of panic disorder. Lancet, 352: 1646-7.

48531 Roy-Byrne PP, Craske MG, Stein MB (2006). Panic disorder. The Lancet, 368: 1023-32.

5795 Roy-Byrne PP, Geraci M, Uhde TW (1986). Life events and the onset of panic disorder. Am J Psychiatry, 143(11): 1424-7.

78620 Ruxton CH (2014). The suitability of caffeinated drinks for children: a systematic review of randomised controlled trials, observational studies and expert panel guidelines. J Hum Nutr Diet, 27(4): 342-57.

43450 Safren SA, Gershuny BS, Marzol P, Otto MW, & Pollack MH (2002). History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. Journal of Nervous and Mental Disease, 190: 453-456.

78619 Salinero JJ, Lara B, Abian-Vicen J, et al (2014). The use of energy drinks in sport: perceived ergogenicity and side effects in male and female athletes. Br J Nutr, 112(9): 1494-502.

78081 Salo R, Flower K, Kielstein A, et al (2011). Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res, 186(2-3): 356-61.

78331 Sansone RA, Sansone LA (2002). Exacerbation of panic disorder symptoms following Vicodin exposure. Gen Hosp Psych, 24: 448-54.

78152 Sapbamrer R, Nata S (2014). Health symptoms related to pesticide exposure and agricultural tasks among rice farmers from northern Thailand. Environ Health Prev Med, 19(1): 12-20.

78392 Saraceno R, Faleri S, Ruzzetti M, et al (2012). Prevalence and management of panic attacks during infliximab infusion in psoriatic patients. Dermatology, 225(3): 236-41.

52094 Sareen J, Cox BJ, Afifi TO, Stein MB, et al (2007). Combat and peacekeeping operations in relation to prevalence of mental disorders and perceived need for mental health care. Arch Gen Psychiatry, 64(7): 843-52.

43439 Sareen J, Cox BJ, Clara I, Asmundson GJG (2005). The relationship between anxiety disorders and physical disorders in the US National Comorbidity Survey. Depression and Anxiety, 21: 193-202.

78245 Sassine MP, Mergler D, Larribe F, et al (1996). Mental health deterioration among workers exposed to styrene [article in French]. Rev Epidemiol Sante Publique, 44(1): 14-24.

51049 Scheutzow MH, Wiercisiewski DR (1999). Panic disorder in a patient with traumatic brain injury: a case report and discussion. Brain Injury, 13(9): 705-14.

52490 Schlegel S, Steinert H, Bockisch A, Hahn K, et al (1994). Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. Eur Arch Psychiatry Clin Neurosci, 244: 49-51.

11824 Schmidt NB, Lerew DR (1997). The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress. Journal of Abnormal Psychology, 106(3): 355-64.

12241 Schmidt NB, Lerew DR (1997). The role of anxiety sensitivity in the pathogenesis of panic: Prospective evaluation of spontaneous panic attacks during acute stress. Journal of Abnormal Psychology, 106(3): 355-64.

of 34

53428 Schmidt NB, Santiago HT, Trakowski JH, Kendren JM (2002). Pain in patients with panic disorder: relation to symptoms, cognitive characteristics and treatment outcome. Pain Res Manage, 7(3): 134-41.

75206 Schneider C, Adamcova M, Jick SS, et al (2013). Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders. Travel Medicine and Infectious Disease, 11: 71-80.

78275 Schneir AB, Cullen J, Ly BT (2011). "Spice" girls: synthetic cannabinoid intoxication. Journal of Emergency Medicine, 40(3): 296-9.

78082 Schuckit MA (2006). Comorbidity between substance use disorders and psychiatric conditions. Addiction, 101(Suppl 1): 76-88.

11854 Schuckit MA, Hesselbrock V (1994). Alcohol dependence and anxiety disorders: what is the relationship? American Journal of Psychiatry, 151(12): 1723-34.

12218 Schweitzer R (1994). Tachycardia and panic attacks. Australian Family Physician, 23(9): 1784-87.

78231 Scott RM, Hides L, Allen S, et al (2010). Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use. Psychopharmacology, 209(1): 25-36.

12229 Seier FE, Kellner M, Yassouiridis A, Heese R, et al (1997). Autonomic reactivity and hormonal secretion in lactate-induced panic attacks. American Journal of Physiology, 272: H2630-H2638.

78330 Senay EC, Adams EH, Geller A, et al (2003). Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug and Alcohol Dependence, 69: 233-41.

78749 Serretti A, Calati R, Goracci A, et al (2010). Antidepressants in healthy subjects: what are the psychotropic/psychological effects. European Neuropsychopharmacology, 20: 433-53.

12490 Servant D & Parquet PJ (1994). Early life events and panic disorder: Course of illness and comorbidity. Prog Neuro-Psychopharmacol & Biol Psychiat, 18: 373-79.

78466 Shah SU, Lqbal Z, White A, et al (2016). Heart and mind: (2) psychotropic and cardiovascular therapeutics. Postgrad Med J, 81: 33-40.

74775 Shahab L, Andrew S, West R (2014). Changes in prevalence of depression and anxiety following smoking cessation: results from an international cohort study (ATTEMPT). Psychological Med, 44: 127-41.

12039 Shalev AY (1993). Post-traumatic stress disorder: a biopsychological perspective. Israel Journal of Psychiatry& Related Science, 30(2): 102-9.

77897 Shanks GD, Oloo AJ, Aleman GM, et al (2001). A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against plasmodium falciparum malaria. Clin Infect Dis, 33(12): 1968-74.

9902 Shavitt RG, Gentil V, Mandetta R (1992). The association of Panic/Agoraphobia and asthma contributing factors and clinical implications. General Hospital Psychiatry, 14: 420-3.

12215 Shear MK (1996). Factors in the etiology and pathogenesis of panic disorder: revisiting the attachment-separation paradigm. American Journal of Psychiatry, 153(7): 125-36.

48533 Shear MK, Cassano GB, Frank E, Rucci P, et al (2002). The panic-agoraphobic spectrum: development, description, and clinical significance. Psychiatr Clin North Am, 25(4): 739-56.

44337 Shih RA, Belmonte PL, Zandi PP (2004). A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. International Review of Psychiatry, 16(4) pp 260-283.

51048 Shipko S (2001). Panic disorder in otolaryngologic practice: a brief review. Ear, Nose & Throat Journal, 80(12): 867-8.

52617 Sholomskas DE, Wickamaratne PJ, Dogolo L, O'Brien DW (1993). Postpartum onset of panic disorder: A coincidental event? J Clin Psychiatry, 54: 476-80.

of 34

12345 Shulman ID, Cox BJ, Swinson RP, Kuch K, et al (1994). Precipitating events, locations and reactions associated with initial unexpected panic attacks. Behaviour Research and Therapy, 32(1): 17-20.

52475 Silove D (1987). Severe threat in the genesis of panic disorder. Aust N Z J Psychiatry, 21: 591-600.

9905 Silove D, Manicavasagar V (1993). Adults who feared school: is early separation anxiety specific to the pathogenesis of panic disorder? Acta Psychiatr Scand, 88: 385-90.

50829

Silver JM, Kramer R, Greenwald S, Weissman M (2001). The association between head injuries and psychiatric disorders: findings from the New Haven NIMH Epidemiologic Catchment Area Study. Brain Injury, 15(11): 935-45.

31718 Sim M, Abramson M, Forbes A, Ikin J, et al (2003). Psychological Health. Australian Gulf War Veterans’ Health Study, 2 11: 268-71. Commonwealth of Australia.

52084 Simon GE, von Korff M, Saunders K, Miglioretti DL, et al (2006). Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry, 63: 824-30.

78751 Sinclair LI, Christmas DM, Hood SD, et al (2009). Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry, 194(6): 483-90.

11820 Singh N, Gayowski T, Wagener MM, Marino IR (1997). Depression in patients with cirrhosis: impact on outcome. Digestive Diseases and Sciences, 42(7): 1421-7.

79365 Sirakov M, Tomova E (2015). Oral contraceptives and mood/sexual disorders in women. [Article in Bulgarian]. Akush Ginekol (Sofiia), 54(5): 34-40. [Abstract]

48313

Skodol AE, Gunderson JG, Shea MT, McGlashan TH, Morey LC, Sanislow CA, et al (2005). The Collaborative Longitudinal Personality Disorders Study (CLPS): Overview and implications. Journal of Personality Disorders, 19: 487-504.

49761 Skodol AE, Oldham JM, Hyler SE, Stein DJ, Hollander E, Gallaher PE, Lopez AE. (1995). Patterns of anxiety and personality disorder comorbidity. J Psychiat Res, 29:361-74.

11816 Skre I, Onstad S, Torgersen S, Lygren S, Kringlen E (1993). A twin study of DSM-III-R anxiety disorders. Acta Psychiatrica Scandinavica, 88: 85-92.

52104 Smits JA, O'Cleirigh CM, Otto MW (2006). Combining cognitive-behavioral therapy and pharmacotherapy for the treatment of panic disorder. Journal of Cognitive Psychotherapy, 20(1): 75-84.

48491 Smoller JW, Gardner-Schuster E, Covino J (2008). The genetic basis of panic and phobic anxiety disorders. Am J Med Genet C Semin Med Genet, 148C: 118-26.

78731

Sommer M, Braumann M, Althoff T, et al (2011). Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controls. Pharmacopsychiatry, 44(4): 129-34.

78029

Soukhathammavong P, Odermatt P, Sayasone S, et al (2011). Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis, 11(2): 110-8.

12227 Southwick SM, Krystal JH, Bremner JD, et al (1997). Noradrenergic and serotonergic function in posttraumatic stress disorder. Archives of General Psychiatry, 54: 749-58.

9898 Sparks PJ, Ayars GH, Simon GE, Katon WJ, et al (1991). Depression and panic attacks related to phenol-formaldehyde composite material exposure in an aerospace manufacturing plant. Allergy Proc, 12(6): 389-93.

of 34

50240 Spencer PS, Schaumburg HH (1985). Organic solvent neurotoxicity. Facts and research needs. Scand J Work Environ Health, 11(Suppl 1): 53-60.

11846 Spiegel D (1996). Cancer and depression. British Journal of Psychiatry, 168(suppl 30): 109-16.

9901 Spinhoven P, Ros M, Westgeest A, Van der Does AJ (1994). The prevalence of respiratory disorders in panic disorder, major depressive disorder and V-code patients. Behav Res Ther, 32(6): 647-9.

53467 Starcevic V, Bogojevic G, Marinkovic J, Kelin K (1999). Axis I and axis II comorbidity in panic / agoraphobic patients with and without suicidal ideation. Psychiatr Res, 88: 153-61.

11826 Starcevic V, Fallon S, Uhlenhuth EH, Pathak D (1994). Comorbidity rates do not support distinction between panic disorder and generalized anxiety disorder. Psychopathology, 27: 269-72.

48524 Starcevic V, Kolar D, Latas M, Bogojevic G, Klein K (2002). Panic disorder patients at the time of air strikes. Depression and Anxiety, 16: 152-6.

9886 Starcevic V, Uhlenhuth EH, Kellner R, Pathak D (1993). Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Psychiatry Research, 46: 285-93.

52611 Stein MB, Walker JR, Anderson G, Hazen AL, et al (1996). Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample. Am J Psychiatry, 153: 275-7.

48521 Stones A, Groome D, Perry D, Hucklebridge F, Evans P (1999). The effect of stress on salivary cortisol in panic disorder patients. Journal of Affective Disorders, 52: 197-201.

78734 Suresh SH, Chakraborty A, Virupakshaiah A, et al (2015). Efficacy and safety of Levetiracetam and Carbamazepine as monotherapy in partial seizures. Epilepsy Research and Treatment, article ID 415082: .

78179 Takahashi N, Hasizume M (2014). A systematic review of the influence of occupational organophosphate pesticides exposure on neurological impairment. BMJ Open, 4: e004798.

34320 Tam SW, Worcel M, Wyllie M (2001). Yohimbine: a clinical review. Pharmacology & Therapeutics, 91(3): 215-43.

78092 Tanner-Smith EE (2008). Corrigendum to "Pharmacological content of tablets sold as "ecstasy": results from an online testing service" [Drug Alcohol Depend. 83(2006)247-254]. Drug Alcohol Depend, 93: 190.

78093 Tanner-Smith EE (2006). Pharmacological content of tablets sold as "ecstasy": results from an online testing service. Drug Alcohol Depend, 83: 247-54.

52095

Tarlo SM, Poonai N, Binkley K, antony MM, Swinson RP (2002). Responses to panic induction procedures in subjects with multiple chemical sensitivity/idiopathic environmental intolerance: understanding the relationship with panic disorder. Environ Health Perspect, 110(Suppl 4): 669-71.

74776 Taylor G, McNeill A, Girling A, et al (2014). Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ, 348(g1151): doi: 10.1136/bmj.g1151.

78386 Telgt DS, van der Ven AJ, Schimmer B (2005). Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection. Ann Pharmacother, 39: 551-4.

77918 Terrell AG, Forde ME, Firth R, et al (2015). Malaria chemoprophylaxis and self-reported impact on ability to work: mefloquine versus doxycycline. J Travel Med, 22(6): 383-8.

78665 Testa A, Giannuzzi R, Sollazzo F, et al (2013). Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases. Eur Rev Med Pharmacol Sci, 17(Suppl 1): 65-85.

51050 Tiet QQ, Mausbach B (2007). Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res, 31(4): 513-36.

of 34

76654 Tran TM, Browning J, Dell ML (2006). Psychosis with paranoid delusions after a therapeutic dose of mefloquine a case report. Malaria Journal, 5: 74.

78182 Treisman GJ, Kaplin AI (2002). Neurologic and psychiatric complications of antiretroviral agents. AIDS, 16: 1201-15.

78289

Trento M, Trevisan M, Raballo M, et al (2014). Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest, 37(1): 79-85.

53470 Tsao JCI, Dobalian A, Naliboff BD (2004). Panic disorder and pain in a national sample of persons living with HIV. Pain, 109: 172-80.

78308 Tsen LC, Datta S (1999). Panic attacks and lactated ringer's solution: is there a relationship? Anesth Analg, 88(4): 795-6.

52481 Tsuang M, Domschke K, Jerskey BA, Lyons MJ (2004). Agoraphobic behavior and panic attack: a study of male twins. Journal of Anxiety Disorders, 18: 799-807.

53474 Ulas H, Alptekin K, Akdede BB, Tumuklu M, et al (2007). Panic symptoms in schizophrenia: comorbidity and clinical correlates. Psychiatry & Clinical Neurosciences, 61: 678-80.

9869 Ushiroyama T, Okamoto Y, Toyoda K, Sugimoto O (1992). A case of panic disorder induced by oral contraceptive. Acta Obstet Gynecol Scand, 71: 78-80.

12664 Vaillant GE (1983). The Natural History of Alcoholism, : 15-180. Harvard University Press, Cambridge Massachusetts.

12225

Van Balkom AJLM, Bakker A, Spinhoven P, Blaauw BMJW, et al (1997). A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioural, and combination treatments. J Nerv Ment Dis, 185(8): 510-16.

48534 van den Heuvel OA, van de Wetering BJM, Veltman DJ, Pauls DL (2000). Genetic studies of panic disorder: a review. J Clin Psychiatry, 61(10): 756-66.

78123 van der Hoeven J, Duyx J, de Langen JJ, et al (2005). Probable psychiatric side effects of azathioprine. Psychosom Med, 67(3): 508.

45039 van Laar M, van Dorsselaer S, Monshouwer K, de Graaf R (2007). Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction, 102(8): 1251-1260.

78031 van Riemsdijk MM, van der Klauw MM, van Heest JA, et al (1997). Neuro-psychiatric effects antimalarials. Eur J Clin Pharmacol, 52(1): 1-6.

78564 van Wijngaarden E (2003). Mortality of mental disorders in relation to potential pesticide exposure. J Occup Environ Med, 45: 564-8.

9884 Vazquez A, Jimenez-Jimenez FJ, Garcia Ruiz P, Garcia-Urra D (1993). "Panic attacks" in Parkinson's disease: A long-term complication of levodopatherapy. Acta Neurol Scand, 87: 14-8.

53469 Venturello S, Barzega G, Maina G, Bogetto F (2002). Premorbid conditions and precipitating events in early-onset panic disorder. Comprehensive Psychiatry, 43(1): 28-36.

12304 Verburg K, de Leeuw M, & Griez E (1997). No dynamic lung function abnormalities in Panic Disorder patients. Biol Psychiatry, 41: 834-36.

9900 Verburg K, Griez E, Meijer J, Pols H (1995). Respiratory disorders as a possible predisposing factor for panic disorder. Journal of Affective Disorder, 33: 129-34.

12217 Verburg K, Griez E, Meijer J, & Pols H (1995). Respiratory disorders as a possible predisposing factor for panic disorder. Journal of Affective Disorder, 33: 129-34.

78232 Verheyden SL, Maidment R, Curran HV (2003). Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health. Journal of Psychopharmocology, 17(4): 371-8.

of 34

78393 Victorri-Vigneau C, Bronnec M, Pretagut S, et al (2008). Anxiety, phobia and Nadolol abuse: a case report. Pharmacopsychiatry, 41(4): 165-6.

77737 Vilarim MM, Araujo DMR, Nardi AE (2011). Caffeine challenge test and panic disorder: a systematic literature review. Expert Review of Neurotherapeutics, 11(8): 1185-95.

51227 Villafuerte S, Burmeister M (2003). Untangling genetic networks of panic, phobia, fear and anxiety. Genome Biology, 4: 224.

52616 Villeponteaux VA, Lydiard RB, Laraia MT, Stuart GW, Ballenger JC (1992). The effects of pregnancy on preexisting panic disorder. J Clin Psychiatry, 53: 201-3.

76872 Visser I, Wekking EM, de Boer AG, et al (2011). Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE). Neurotoxicology, 32(6): 916-22.

70941

Vogt D, Vaughn R, Glickman ME, et al (2011). Gender differences in combat-related stressors and their association with postdeployment mental health in a nationally representative sample of U.S. OEF/OIF veterans. J Abnorm Psychol, 120(4): 797-806.

78389 Vorspan F, Mehtelli W, Dupuy G, et al (2015). Anxiety and substance use disorders: co-occurrence and clinical issues. Curr Psych Reports, 17: 4.

78133 Wagner KD (1996). Major depression and anxiety disorders associated with Norplant. J Clin Psychiatry, 57(4): 152-7.

48537 Wagner KD (2006). Bipolar disorder and comorbid anxiety disorders in children and adolescents. J Clin Psychiatry, 67(Suppl 1): 16-20.

48501 Wagner KD (2006). Bipolar disorder and comorbid anxiety disorders in children and adolescents. J Clin Psychiatry, 67(Suppl 1): 16-20.

9870 Wagner KD, Berenson AB (1994). Norplant-associated major depression and panic disorder. J Clin Psychiatry, 55(11): 478-80.

75207 Walker RA, Colleaux KM (2007). Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis. Can J Ophthalmol, 42: 125-6.

78325

Wallace MS, Kosek PS, Staats P, et al (2008). Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Pain Medicine, 9(3): 271-81.

78020 Walsh DS, Eamsila C, Sasiprapha T, et al (2004). Efficacy of monthly tafenoquine for prophylaxis of plasmodium vivax and multidrug-resistant p. falciparum malaria. J Infect Dis, 190(8): 1456-63.

78023

Walsh DS, Looareesuwan S, Wilairantana P, et al (1999). Randomized dose-ranging study of the safety and efficacy or WR238605 (tafenoquine) in the prevention of relapse of plasmodium vivax malaria in Thailand. J Infect Dis, 180(4): 1282-7.

48513 Wang AG, Dahl HA, Vang M, Als TD, et al (2006). Genetics of panic disorder on the Faroe Islands: a replication study of chromosome 9 and panic disorder. Psychiatric Genetics, 16: 99-104.

78126 Warnock JK, Bundren JC (1997). Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy. Psychopharmacol Bull, 33(2): 311-6.

12226

Warshaw MG, Massion AO, Shea MT, Allsworth J, et al (1997). Predictors of remission in patients with panic and without agoraphobia: prospective 5-year follow-up data. The Journal of Nervous and Mental Disease, 185(8): 517-9.

78180 Watanabe S, Kitamura K, Nagahashi M (1999). Effects of dioxins on human health: a review. J Epidemiol, 9: 1-13.

75208 Weinke T, Trautmann M, Held T, et al (1991). Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg, 45(1): 86-91.

78243 Weiss KJ (1996). Optimal management of anxiety in older patients. Drugs & Aging, 9(3): 191-201.

of 34

9893 Weissman MM (1992). The epidemiology and genetics of panic disorder. Clin Neuropharm, 15(suppl 1): 18A-9A.

11829 Weissman MM, Bland RC, Canino GJ, Faravelli C, et al (1997). The cross-national epidemiology of panic disorder. Arch Gen Psychiatry, 54: 305-9.

77259 Wells TS, Smith TC, Smith B (2006). Mefloquine use and hospitalizations among US service members, 2002-2004. Am J Trop Med Hyg, 74(5): 744-749.

78157

Wesseling C, van Wendel de Joode B, Keifer M, et al (2010). Symptoms of psychological distress and suicidal ideation among banana workers with a history of poisoning by organophosphate or n-methylcarbamate pesticides. Occup Environ Med, 67(11): 778-84.

70455 While A, Keen L (2012). The effects of statins on mood: a review of the literature. Eur J Cardiovasc Nurs, 11(1): 85-96.

9873 Whitaker-Azmitia PM, Aronson TA (1989). "Ecstasy" (MDMA)-induced panic. Am J Psychiatry, 146(1): 119.

52494 White-Van Mourik MCA, Connor JM, Ferguson-Smith MA (1992). The psychosocial sequelae of a second-trimester termination of pregnancy for fetal abnormality. Prenatal Diagnosis, 12: 189-204.

78388 Whiting PF, Wolff RF, Deshpande S, et al (2015). Cannabinoids for medical use: a systematic review and meta-analysis. JAMA, 313(24): 2456-73.

78667 WHO Technical Report Series (2015). WHO expert committee on drug dependence - thirty-sixth report. World Health Organ Tech Rep Ser, 991. .

78666 WHO Technical Report Series (2012). WHO expert committee on drug dependence - thirty-fifth report. World Health Organ Tech Rep Ser, 973. .

23848 Wilkinson DJC, Thompson JM, Lambert GW et al (1998). Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry, 55(6): 511-20.

78467 Williamson S, Gossop M, Powis B, (1997). Adverse effects of stimulant drugs in a community sample of drug users. Drug and Alcohol Dependence, 44: 87-94.

75209 Wise M, Toovey S (2007). Reversible hearing loss in temporal association with chemoprophylactic mefloquine use. Travel Medicine and Infectious Disease, 5: 385-8.

52483 Wisner KL, Peindl KS, Hanusa BH (1996). Effects of childbearing on the natural history of panic disorder with comorbid mood disorder. J Affect Disord, 41: 173-80.

53473 Witgert ME, Wheless JW, Breier JI (2005). Frequency of panic symptoms in psychogenic nonepileptic seizures. Epilepsy & Behavior, 6: 174-8.

12348 Wittchen H-U (1996). Critical issues in the evaluation of comorbidity of psychiatric disorders. British Journal of Psychiatry, 168(Suppl 30): 9-16.

9890 Wittchen H-U, Essau CA (1993). Epidemiology of panic disorders: Progress and unresolved issues. J Psychiat Res, 27(suppl 1): 47-68.

11825 Wittchen HU, Essau CA (1993). Epidemiology of panic disorder: progress and unresolved issues. Journal of Psychiatric Research, 27(Suppl 1): 47-68.

41517 Wittchen H-U, Kessler RC, Pfister H, Lieb M (2000). Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand, 102(Suppl 406): 14-23.

78668 Yang A, Palmer AA, de Wit H (2010). Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl), 211(3): 245-57.

9879 Young SJ (1996). Panic associated with combining fluoxetine and bupropion. J Clin Psychiatry, 57(4): 177-8.

53468 Zaider TI, Johnson JG, Cockell SJ (2000). Psychiatric comorbidity associated with eating disorder symptomatology among adolescents in the community. Int J Eat Disord, 28: 58-67.

49744 Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. (1998). Axis I comorbidity of borderline personality disorder. Am J Psychiatry, 155:1733-1739.

of 34

48316

Zanarini MC, Frankenburg FR, Hennen J, Reich DB & Silk KR (2005). The McLean Study of Adult Development (MSAD): Overview and implications of the first six years of prospective follow-up. Journal of Personality Disorders, 19: 505-23.

9906 Zandbergen J, Bright M, Pols H, Fernandez I, de Loof C, Griez EJL (1991). Higher lifetime prevalence of respiratory diseases in panic disorder? American Journal of Psychiatry, 148: 1583-5.

78154 Zhang X, Wu M, Yao H, et al (2016). Pesticide poisoning and neurobehavioral function among farm workers in Jiangsu, people's republic of China. Cortex, 74: 396-404.

11853 Zinbarg RE, Barlow DH, Liebowitz M, Street L, et al (1994). The DSM-IV field trial for mixed anxiety-depression. American Journal of Psychiatry, 151(8): 1153-62.

9881 Zinner SH (1994). Panic attacks precipitated by sertraline. Am J Psychiatry, 151(1): 147-8.

78230 Zubaran C, Foresti K, Thorell MR, et al (2013). Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil. Rev Assoc Med Bras, 59(4): 360-7.

48511

Zvolensky MJ, Bernstein A, Sachs-Ericsson N, Schnmidt NB, et al (2006). Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. Journal of Psychiatric Research, 40(6): 477-86.

49075 Zvolensky MJ, Bernstein A, Marshall EC, Feldner MT (2006). Panic attacks, panic disorder, and agoraphobia: Associations with substance use, abuse, and dependence. Curr Psych Reports, 8: 279-85.

78277 Zvolensky MJ, Farris SG, Guillot CR, et al (2014). Anxiety sensitivity as an amplifier of subjective and behavioral tobacco abstinence effects. Drug Alcohol Depend, 142: 224-30.

48530 Zvolensky MJ, Feldner MT, Leen-Feldner EW, McLeish AC (2005). Smoking and panic attacks, panic disorder, and agoraphobia: a review of the empirical literature. Clinical Psychology Review, 25: 761-89.

48525 Zvolensky MJ, Kotov R, Antipova AV, Schmidt NB (2005). Diathesis stress model for panic-related distress: a test in a Russian epidemiological sample. Behaviour Research and Therapy, 43: 521-32.

52100 Zwanger P, Rupprecht R (2005). Selective GABAergic treatment for panic? Investigations in experiemental panic induction and panic disorder. J Psychiatry Neurosci, 30(3): 167-75.

Reference list concerning panic disorder€¦ · cingulate cortex volume reduction in patients with...

Documents

Transcript of Reference list concerning panic disorder€¦ · cingulate cortex volume reduction in patients with...